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ABSTRACT
A PLATFORM FOR THE DISCOVERY AND CHACTERIZATION OF PROTEINS THAT
ASSOCIATE WITH PSEUDOMONAS AERUGINOSA RNA POLYMERASE
By
Danielle N. Brogren
Pseudomonas aeruginosa is an opportunistic bacterial pathogen notable for its ability to
colonize the lungs of cystic fibrosis patients. Once the bacterium infects and colonizes humans, it
is extremely difficult to eradicate. This leads to long-term infections that significantly damage
the lungs and other tissues. P. aeruginosa infections are challenging to treat due to the
bacterium’s natural antibiotic resistance and the rise of multidrug resistant strains. Development
of novel drug treatments are a necessity.
In all organisms, the regulation of gene expression is a highly controlled process.
Remarkably, in P. aeruginosa bioinformatics studies showed that 20% of its genome is dedicated
to regulating transcription, the first stage of gene expression. However, the vast majority of
proteins that regulate transcription in P. aeruginosa are poorly understood. Understanding gene
regulation is a promising strategy for discovery of novel drug targets. RNA polymerase (RNAP)
is an essential enzyme controlling gene regulation, and its activity is modulated through a
plethora of transcription factors or other proteins. The regulation of gene expression has been
best studied in E. coli.
The aim of this work was to develop a platform to study RNAP-interacting proteins in P.
aeruginosa. To do this, we took advantage of an E. coli RNAP “coreome” library. The RNAP
“coreome” was a term developed to describe 38 different plasmids each expressing surface
exposed regions of RNAP inputted into a bacterial two-hybrid assay. In general, RNAP is a
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highly conserved enzyme among bacteria. Alignments of the amino acids of each piece of the E.
coli RNAP coreome to specific domains of P. aeruginosa RNAP have shown a high degree of
similarity (between 82-100%). The coreome was constructed based on the high-resolution
structure of the bacteria Thermus aquaticus RNAP suggesting that E. coli β RNAP can be parsed
into 10 sub-domains. Analysis of the E. coli β’ subunit of RNAP suggested that it could be
parsed into 18 sub-domains that cover the entire gene (Nickels, 2009).
A bacterial two-hybrid assay can be utilized to determine if a specific target protein
interacts with domains of RNAP found within the RNAP coreome. Data from the IntAct
Molecular Interaction Database identified 147 E. coli proteins that directly or indirectly interact
with RNAP. We performed a bioinformatic analyses to identify P. aeruginosa homologs to these
E. coli proteins. Initially, sixteen P. aeruginosa proteins were screened against the E. coli RNAP
coreome in the bacterial two-hybrid assay.
In this work five P. aeruginosa proteins, AlgQ, NusG, ClpA, DppF, and Tig were shown
to interact with particular fragments of the E. coli RNAP coreome. Specifically, we show that
AlgQ interacted with σ 528-613, NusG interacted with β’249-328 and β’264-308, ClpA
interacted with β 829-930 and β 831-1059, DppF interacted with β' 114-190 and β 1137-1226,
and Tig interacted with β' 735-790 and β 450-530. These results indicate the E. coli RNAP
coreome can be utilized to uncover RNAP-interacting proteins in P. aeruginosa and to discover
the precise domains they contact. In the future if the RNAP-binding determinants or proteins that
control expression of virulence factors are identified using the RNAP coreome, it may be
possible to design novel drugs that either disrupt the function of those proteins or their
interaction with RNAP. Ultimately, this could lead to improved treatment options for P.
aeruginosa infections.
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INTRODUCTION

Pseudomonas aeruginosa is a metabolically versatile bacteria, which can be
found in numerous niches including soil, marine habitats, and on animal and plant tissues
(Stover et al., 2000). Being an opportunistic pathogen, P. aeruginosa generally poses no
threat when it comes into contact with an immunocompetent human host (Lang et al.,
2004). However, immune compromised individuals, such as cancer patients, burn
victims, and patients with cystic fibrosis (CF) are more susceptible to infection with this
pathogen (Hirsch & Tam, 2010).
P. aeruginosa is naturally resistant to a number of antibiotics because it contains
membrane proteins that transport toxic substances out of the cell. Multidrug efflux
systems (MES) such as the MexAB-OprM are efficient membrane pumps that allow the
natural resistance to a number of antibacterial agents including β-lactams, β-lactamase
inhibitors, quinolones, chloramphenicol and tetracycline (Aires et al., 1999). Apart from
antibacterial agents, the Mex efflux system of P. aeruginosa can also cause resistance to
a number of organic solvents, biocides, dyes, and cell signaling molecules (Papadopoulos
et al., 2008).
P. aeruginosa also possesses numerous virulence factors that allows it to
successfully colonize diverse regions of its host. Such virulence factors include adhesions
that are responsible for binding to epithelial cells and exotoxins that disrupt immune
clearance mechanisms (Tang et al., 1996). The number of carbapenem resistant P.
aeruginosa infections has also been on the rise. These are especially dangerous since
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carbapenem is often the antibiotic of last resort to treat P. aeruginosa infections
(Livermore, 2002). All of these factors contributes to the difficulty of treating P.
aeruginosa infections, making it necessary to develop novel treatments (Stover et al.,
2000).
One of the groups most vulnerable to P. aeruginosa infections are patients with
CF. At age 20, up to 80% of CF patients suffer from chronic lung infection with P.
aeruginosa (Lang et al., 2004). The immune system is not successful at eradicating the
infection and causes massive inflammation leading to the destruction of lung tissue and
ultimately lung function (Emerson et al., 2002;Lang et al., 2004). In burn patients, a 77%
mortality rate was seen with P. aeruginosa infections (Lyczak et al., 2000). Development
of antibiotic resistance in P. aeruginosa in these vulnerable patient populations is also
problematic. Other therapies are required to treat this pathogen, and one area of research
that may be promising focuses on disrupting transcription factor (TF) function/RNAPinteracting proteins.
In all organisms, transcription, and regulation of gene expression is a highly
regulated process. Remarkably, P. aeruginosa bioinformatics studies showed that 20% of
its genome is dedicated to regulating transcription, approximately 1,200 proteins (Stover
et al., 2000). In comparison, E. coli has only 10% of its genome dedicated to regulating
transcription (Blattner et al., 1997). Regulation of transcription can occur by modulating
the activity of RNA polymerase (RNAP), often through the action of TFs. A better
understanding of gene regulation in P. aeruginosa, specifically through the role of TFs,
could lead to the discovery of new targets for antibiotic design.
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The objective of this study is to identify potential TFs and other RNAPinteracting proteins or other proteins that interact with RNAP. In E. coli, 147 proteins
were shown to either directly or indirectly interact with RNAP (see Table 1). Because E.
coli and P. aeruginosa are in the same class of bacteria, gammaproteobacteria, it is likely
that these E. coli RNAP-interacting proteins could be functioning as RNAP-interacting
proteins in P. aeruginosa.
Compared to E. coli, much less is known about transcriptional regulation in P.
aeruginosa. By utilizing the protein-protein interaction database (IntAct Molecular
Interaction Database-www.ebi.ac.uk/intact), a list of E. coli RNAP-interacting proteins
was obtained. From here, bioinformatic analysis was performed to identify specific
homologs to these E. coli proteins in P. aeruginosa. Using this approach, sixteen P.
aeruginosa homologs were selected for further analysis in the bacterial two-hybrid assay
based on the following criteria: (1) The P. aeruginosa proteins must have been greater
than 70% identical to its E. coli counterpart, and (2) They must have had no previously
described interactions with RNAP in P. aeruginosa. As controls, two P. aeruginosa
proteins were chosen that had previously described interactions with RNAP. These were
AlgG and NusG. All proteins selected for further investigation in this study are shown in
Table 6.
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Table 1. List of E. coli proteins that were shown to be associated with binding
directly or indirectly to RNAP. The proteins highlighted in yellow are the initial
putative TFs that have significant similarity in P. aeruginosa and will be utilized in
the bacterial two-hybrid assay. ♥= genes that have been cloned into the pBRα
expression vector. Shaded boxes indicate TFs with literature evidence implicating
a particular binding site domain on RNAP. One of these proteins (NusG) will be
used as a control. (IntAct Molecular Interaction Database-www.ebi.ac.uk/intact).
Table 1 was modified from the original table created by Padraig Deighan.

4

LITERATURE REVIEW

Pseudomonas aeruginosa
Pseudomonas aeruginosa is a versatile Gram-negative bacterium that is found in
soil, marine habitats, and on plant and animal tissues. The emergence of P. aeruginosa as
an opportunist pathogen is due to its increasing resistance to antibiotics and disinfectants
(Stover et al., 2000). P. aeruginosa is known to form biofilms on various surfaces, where
these biofilms are important for its colonization and persistence in many patients, such as
burn victims, patients that have implanted medical devices such as catheters and
respirators, patients that have urinary tract infections (UTI) and hospital-acquired
pneumonia (Sadikot et al., 2005).
The ubiquitous nature of P. aeruginosa is due to its ability to utilize diverse
sources of carbon and other nutrients (Stover et al., 2000). With a genome of 6.3 million
base pairs (Mbp), which is about 50% bigger than average bacteria, a larger number of
open reading frames (ORFs), and 20% of its genome dedicated to gene regulation, P.
aeruginosa is metabolically versatile. This metabolic versatility allows P. aeruginosa to
thrive in diverse hosts and environments. There are many potential sources of nutrients P.
aeruginosa encounters in these different environments and its ability to adjust its
metabolism accordingly is crucial for its survival (Stover et al., 2000).
P. aeruginosa is most notable for lung colonization of cystic fibrosis (CF)
patients, contributing to severe morbidity and mortality. Once colonization occurs, P.
aeruginosa is almost impossible to eradicate due to its natural resistance to antibiotics,
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leading to pulmonary failure and death (Stover et al., 2000). About 30% of CF infants can
obtain strains of P. aeruginosa from the environment, triggering acute infection. By the
age of 3, the rate of infection increases to nearly 50%. Some individuals end up acquiring
mucoid phenotypes leading to chronic infections (Moradali et al., 2017). Cystic fibrosis
patients suffering from chronic lung infections are exposed to an overproduction of
alginate, an exopolysaccharide. This overproduction contributes to the persistence of the
bacterium in the CF lung (Suh et al., 1999). P. aeruginosa ability to quickly adapt and
persist in the CF lung causes a 70% mortality rate in adults (Moradali et al., 2017).
Additionally, P. aeruginosa is largely implicated in hospital-acquired infections
including ventilator-associated pneumonia, UTI’s, surgically implanted devices and
central line-associated bloodstream infections (Hirsch & Tam, 2010; Moradali et al.,
2017). From 1986-2003, the National Nosocomial Infections Surveillance reported that
P. aeruginosa was the second most common cause of pneumonia (18.1%), the third most
common UTI (16.3%), and the eight most common pathogen isolated from the blood
stream (3.4%) (Hirsch & Tam, 2010). The prevalence of P. aeruginosa in healthcare
settings is common because of its ability to live on abiotic and biotic surfaces such as
medical devices while being resistant to various disinfectants and enabling frequent
transmission from patient-to-patient (Moradali et al., 2017).
P. aeruginosa infections are challenging to treat with antibiotics due to the
bacterium’s natural resistance and the rise of multidrug resistant strains worldwide.
Resistance to common antibiotic classes include carbapenems, cephalosporins,
fluoroquinolones and aminoglycosides (Moradali et al., 2017). Biofilm formation in P.
aeruginosa is a highly regulated process. These cells respond to various external signals
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including the nutrients in the environment, or lack thereof (O’Toole & Kolter, 1998).
Biofilms allow for the adherence to diverse surface types. This capacity to form biofilms
impacts human health. It aids in P. aeruginosa’s ability to colonize medical devices,
often leading to chronic infections. Other benefits afforded by the biofilm include
protection from host defenses and resistance to antibiotics and disinfectants (López et al.,
2010; O’Toole & Kolter, 1998).
The reduced permeability of the P. aeruginosa outer membrane, coupled with
multiple multidrug efflux systems (MES) account for the mechanisms that underlie its
natural resistance to antibiotics and disinfectants. Many of the P. aeruginosa MES
proteins are in the resistance-nodulation-cell division (RND) family that allows the efflux
of antimicrobial substrates P. aeruginosa has twelve RND efflux systems, and of these
four RND pumps contribute significantly to antibiotic resistance: MexAB-OprM,
MexCD-OprJ, MexEF-OprN, and MexXY-OprM (Dreier & Ruggerone, 2015).
Overexpression of these four systems can result in broad antimicrobial resistance
causing multidrug resistance (Hirsch & Tam, 2010). Each RND pump transports out or
accepts specific antibacterial agents. MexB transports β-lactams. MexD recognizes
fluoroquinolones, zwitterionic cephalosporins, macrolides, chloramphenicol,
trimethoprim, and tetracyclines. MexF accepts fluoroquinolones, chloramphenicol,
trimethoprim, and tetracycline as substrates. MexY transports aminoglycosides,
fluoroquinolones, macrolides, tetracyclines, tigecycline, and zwitterionic cephalosporins
(Dreier & Ruggerone, 2015).
Multidrug resistant P. aeruginosa is resistant to virtually all classes of antibiotics.
Carbapenems are typically the drug of last resort to treat P. aeruginosa infections. With
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the rise of carbapenem-resistant P. aeruginosa infections, other treatment methods are a
high research priority (Dreier & Ruggerone, 2015). The World Health Organization
(WHO) generated a list of bacteria for which new antibiotics are urgently needed in
February 2017. Second on the priority list was carbapenem-resistant P. aeruginosa.
http://www.who.int/mediacentre/news/releases/2017/bacteria-antibiotics-needed/en/
In addition to being naturally resistant to many antibiotics, P. aeruginosa has
numerous virulence factors that contribute to this pathogen’s success. Virulence factors in
this organism range from toxins delivered through protein secretion pathways (i.e. type 1,
2 and 3 secretion systems) to biofilm formation on lung epithelial cells or surgical
implants. P. aeruginosa also consist of two quorum sensing (QS) systems; the LasR–LasI
and the RhlR–RhlI, with the cognate signal molecules N‐(3‐oxo‐dodecanoyl)‐l‐
homoserine lactone (OdDHL) and N‐buturyl‐l‐homoserine lactone (BHL). Both systems
induce production of key virulence factors such as exoproteases, siderophores, exotoxins
and several secondary metabolites (Hentzer et al., 2003). Targeting these mechanisms
and specific proteins that are crucial for P. aeruginosa survival and understanding what
regulates the expression of these genes could lead to novel drug therapies (Stover et al.,
2000).
A large number of P. aeruginosa genes are involved in transcription regulation
(Stover et al., 2000). Our understanding of transcription factors (TFs) and other proteins
that interact with RNA polymerase (RNAP) in P. aeruginosa is very limited. A bacterial
two-hybrid assay will allow us to dissect protein-protein interactions with RNAP. This
work will contribute to a better understanding of how TFs and other proteins interact with
RNAP in P. aeruginosa.
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RNAP is an enzyme that is essential for all life. RNAP initiates and regulates the
expression of genes by transcribing a DNA sequence into mRNA (Yuan et al., 2008). TFs
are proteins that can interact with RNAP to modulate its activity by either activating or
repressing gene expression. Transcription factors and other RNAP-interacting proteins
therefore play an essential role in the process of gene regulation by controlling which
genes can be turned on or off by RNAP. A bacterial two-hybrid assay was developed in
order to gain a better understanding of protein-protein interaction within cells.

Bacterial Two-Hybrid Assay
A transcription activation-based bacterial two-hybrid assay was developed by
Dove et al. (1997) to gain a better understanding of protein-protein interaction within
cells. This has been an effective tool to studying protein interactions from any organism
within E. coli. The assay has been used extensively to study direct interaction with
proteins with the various structural domains of RNAP.
In this assay a sufficiently strong interaction between any two proteins can
activate transcription of a reporter gene if one of the interacting proteins is fused to the
DNA-binding domain of the bacteriophage λcI protein, and the other protein of interest is
fused to the α-subunit NTD of E. coli RNAP (Dove & Hochschild, 2004). Thus, the
genes encoding the proteins of interest are expressed from two different plasmids,
designated as either the “bait” or “prey” plasmid. The bait protein is fused to the λcI
protein. The prey plasmid expresses the other protein under study fused to the NTD of E.
coli RNAP. The strength of the protein-protein interaction between the two proteins
defines the amount of reporter gene activation (Dove and Hochschild, 2004). Figure 1
contains a diagram of a bacterial two-hybrid assay.
9

Figure 1: Basic structure of a bacterial two-hybrid assay. Y is the bait protein fused to λcI
and X is the prey protein fused to the α-subunit unit of RNAP. If there is a strong
interaction between X and Y the reporter gene will be expressed. αNTD is the alpha
subunit of RNAP. -35 and -10 are the promoter regions. lacZ encodes β-galactosidase.
Use of the two-hybrid assay to study regulatory proteins for known interactions
with RNAP
A vital step in the analysis of TF function is to determine whether the regulatory
factor makes direct contact with RNAP. However, determining whether a protein makes
direct contact with RNAP and identifying specifically where it binds on the enzyme can
be challenging (Nickels, 2009). The bacterial two-hybrid assay can be used for various
applications that allow dissection of any protein-protein interactions, including those
involved in gene regulatory circuits. Here are a few examples of the utilization of the
bacterial two-hybrid assay to show protein-protein interaction.
E. coli Rsd protein has been suggested to function as a σ70-specific anti σ factor
first identified by Jishage and Ishihama in 1998. Rsd is produced at the onset of
stationary phase of growth and is found in a complex with σ70 in stationary cell extracts
(Yuan et al., 2008). Biochemical analysis was performed and Rsd was shown to associate
specifically with σ70, inhibiting transcription from certain σ70-dependent promoters in
reactions containing purified Rsd and purified RNAP holoenzyme (Yuan et al., 2008).
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P. aeruginosa encodes a transcriptional regulator known as AlgQ. This protein
has a 55% amino acid sequence similarity with E. coli Rsd. AlgQ regulates the
production of several virulence factors in P. aeruginosa, one of particular interest is
alginate. The primary sigma factors share four regions of conserved sequences (regions
1-4). Regions 2 and 4 have DNA-binding domains that recognize the conserved elements
-10 and -35 elements of σ70– dependent promoters, respectively region 2 also interacts
with the coiled domain of the β’ subunit that is critical for holoenzyme formation. Region
4 also interacts with the β subunit flap domain (β-flap). This interactions positions the
region 4 in contact with the promoter -35 element when region 2 is bound to a -10
element (Yuan et al., 2008).
Several studies suggested that Rsd binds with σ70 region 4. A high-resolution
crystal structure reveals that Rsd affects the binding of σ70 to both the -35 element and the
β-flap. To investigate further the function of Rsd, mutants were constructed and a genetic
screen was used to identify mutants that act as potential inhibitors of σ70–dependent
transcription than wild-type Rsd (Yuan et al., 2008).
Because previously described interaction of Rsd with σ70 region 4 were already
known, Rsd substitutions were tested using a bacterial two-hybrid assay. σ70 interactions
with region 2 was also tested. A bacterial two-hybrid assay adapted and then used to
detect bridging interactions between Rsd and AlgQ. These serve as protein bridges to link
two fused protein domains (σ70 region 2 and σ70 region 4) that do not interact directly
(Yuan et al., 2008).
It was found that both Rsd and AlgQ interact simultaneously with regions 2 and 4
of σ70 (Figure 2), indicating that they both have the possibility to form interfaces with
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full-length σ70. AlgQ, originally identified for the production of alginate, was found to
influence expression of multiple virulence factors including pyocyanin. With the use of
the bacterial two-hybrid assay this allowed further investigation of interactions of the
proteins of interest (AlgQ and Rsd) with RNAP.

Figure 2: A bacterial two-hybrid assay used to detect protein–protein interactions
between Rsd and σ70. Rsd interacts with σ70 region 2. Rsd, indicated as Y fused to the
bacteriophage λcI protein, and σ70 region 4 indicated as X fused to the α-N-terminal
domain (α-NTD). The interaction between X and Y activates transcription from the test
promoter and drives the expression of lacZ. -35 and -10 are the promoter regions. lacZ
encodes β-galactosidase.
Use of the two-hybrid assay to study regulatory proteins of unknown interactors
Chlamydia trachomatis, an intracellular human pathogen, undergoes
developmental programs between two forms: the infectious elementary body (EB), and
the rapidly dividing reticulate body (RB). However, regulators of this developmental
process are not known. To identify potential regulators of transcription in C. trachomatis,
a genomic library for sequences encoding proteins interacting with RNAP were screened.
It was found that CT663 interacts with the β and σ subunits of RNAP (Rao et al., 2009).
The bacterial two-hybrid assay was used to characterize the protein interaction of CT663
with the β-flap domain (bait plasmid) of C. trachomatis of RNAP (Rao et al., 2009).
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A bacterial two-hybrid was then used to dissect specific amino acid residues in
the β-flap that mediated the CT663/β–flap interaction. Figure 3 depicts the bacterial twohybrid assay used to screen the C. trachomatis protein library against the β-flap domain
of RNAP. This screen identified 4 candidate plasmids that encoded in-frame fusion
proteins. One plasmid pBRL28, corresponds to the position of 760498-761436 of the C.
trachomatis of serovar D genome (GenBank ID: NC_000117) that encodes CT663 and
CT664, both of which encode proteins of unknown functions. Protein BLAST analysis
was performed and identified CT633 as a type III chaperone in enteropathogenic E. coli.
CT664 was identified as a member of the fork-head-associated domain family.
With the use of the bacterial two-hybrid assay, isolation and characterization of
CT663 was identified (Figure 3). Originally, studying gene regulation in C. trachomatis
was rather difficult due to the lack of a tractable genetic system for this organism. With
further studies CT663 was found to inhibit transcription in vitro by RNAP with either
σ70or a σ70/66 hybrid and is likely independent of σ66 – dependent transcription (Rao et al.,
2009).
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Figure 3: CT663 interaction with β-flap of RNAP. A bacterial two-hybrid assay was
utilized to screen C. trachomatis DNA library for proteins that could potentially interact
with β-flap domain of RNAP. β-flap fused to the bacteriophage λcI protein, and C.
trachomatis DNA library fused to the α-N-terminal domain (αNTD). The interaction
between C. trachomatis DNA library and β-flap domain of RNAP activates transcription
from the test promoter and drives the expression of lacZ. -35 and -10 are the promoter
regions. lacZ encodes β-galactosidase.
Use of the two-hybrid assay to study a phage encoded inhibitor of RNA synthesis
Phage G1 gp67 was identified as an inhibitor of cell growth and RNA synthesis
when expressed in Staphylococcus aureus. Gp67 was found to interact directly with
region 4 of the primary σ factor in S. aureus, σA (Montero-Diez et al., 2013). Previous
studies indicated that gp67 inhibits transcription from the rRNA promoters but is not
influencing transcription from cellular promoters (Montero-Diez et al., 2013).
The use of an E. coli RNAP components to analyze gp67 was not feasible because
there are no interactions between gp67 and E. coli σ70. However, amino acid substitutions
in σ70 region 4 were introduced that enabled an interaction with gp67 (Montero-Diez et
al., 2013). This amino acid substitution was selected due to some sequence divergence
between Gram-positive and Gram-negative bacteria (Montero-Diez et al., 2013) .
An E. coli-based transcription system was then used to study transcription from
identical rRNA promoters that either contain or do not contain the UP element. The UP
element is a component of bacterial promoters located upstream of the −35 hexamer,
increases transcription by interacting with the RNA polymerase α-subunit. The bacterial
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two-hybrid assay identified the strong inhibitory effect of gp67 on rrnB P1 transcription
and the independence of the UP element and αCTD as depicted in Figure 4.

Figure 4: Bacterial two-hybrid assay used to dissect the gp67-σ4 interaction. The diagram
shows how the interaction between σ4 fused to the RNAP α-N terminal domain (NTD)
and gp67 or β-flap fused to the bacteriophage λcI protein activates the transcription of a
lacZ reporter gene. -35 and -10 are the promoter regions. lacZ encodes β-galactosidase.
Use of the two-hybrid assay to study the interaction between AsiA and RNAP
Bacteriophage T4 AsiA makes direct contact with the β-flap domain of RNAP.
This protein inhibits transcription at E. coli σ70– dependent promoters. Prior research has
established AsiA-dependent transcription inhibition depends on an interaction with
region 4 of σ70. A bacterial two-hybrid assay was used to demonstrate the interaction
between AsiA and β-flap of RNAP and that it interacts simultaneously with β-flap and
region 4 of σ70 as depicted in Figure 5 (Yuan et al, 2009).
Because β-flap and region 4 of σ70 interact directly without bridging proteins,
previously characterized amino acid substitutions in σ70 region (L607P) that disrupt σ70
region 4/β-flap interaction but doesn’t affect the σ70region 4/AsiA interactions were used.
The bacterial two-hybrid assay was conducted and an increase in lacZ was observed
when AsiA was introduced into cells containing fusion proteins. Furthermore, to verify
that the AsiA- dependent increase in transcription required both AsiA/β-flap interaction
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and the σ70region 4/AsiA, each interaction was disrupted utilizing a bacterial two-hybrid
assay.

Figure 5: The bacterial two-hybrid assay was used to detect protein-protein interaction
between AsiA indicated as Y fused to λcI and β-flap indicated as X fused to the α-N
terminal domain (αNTD). The interaction between X and Y activates transcription from
the test promoter and drives the expression of lacZ. -35 and -10 are the promoter regions.
lacZ encodes β-galactosidase.

RNA polymerase
Transcription in bacteria relies on a multi-subunit DNA-dependent RNA
polymerase (RNAP) that binds with a key sigma (σ) factor to complete the holoenzyme.
The complete holoenzyme has 6 subunits: β, β’, αI, αII, ω, and σ. The completion of the
holoenzyme by σ factor allows the recognition of different promoters where specific
initiation can begin (Yuan et al., 2008). RNAP is an essential enzyme controlling gene
regulation where activity is modulated through transcription factors (TFs). TFs are
proteins that interact with RNAP to control its activity and alter gene expression (Lee et
al., 2012).
RNAP core enzyme consist of 5 subunits: β, β’, αI, αII , and ω that are conserved
in sequence, structure, and function in all organisms (Minakhin et al., 2001). The core
enzyme structure is similar to a crab claw. β, β’, the two largest catalytic subunits,
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comprise the bulk of the enzyme and make up the crab claw pincers (one on each end)
(Vassylyev et al., 2007). The α subunit is split into 2 domains, the N-terminal and Cterminal domains (αNTD and αCTD) that are connected by a flexible unstructured linker
(Ross et al., 2003). The αNTD is the primary determinant for dimerization and interacts
with β, β’ (Gaal et al., 1996). The αCTD interacts with UP elements (a component of the
promoter region located upstream of the −35 hexamer), transcription activators, and is
responsible for DNA binding. The ω subunit facilitates the binding of the β’ to αI, αII β to
assemble the enzyme (Vrentas et al., 2005). Figure 6 depicts a simple cartoon of a
bacterial RNAP and the subunits β, β’, αI, αII, and σ.

Figure 6: Diagram of the bacterial RNAP holoenzyme showing the arrangements of β, β’,
α, and σ indicating binding to promoter regions -10 and -35. A transcription start site is
indicating by +1.Image obtained from
https://www.google.com/search?q=rnap&biw=1366&bih=643&source=lnms&tbm=isch
&sa=X&ved=0ahUKEwiLtKiLgq3NAhVCdj4KHaOFD48Q_AUIBigB#imgrc=lFT7fEN
b_zzSTM%3A
Sigma Factors
Sigma (σ) factor, a subunit of bacterial RNAP, plays an essential role in specific
promoter recognition to initiate transcription. σ binds to the core enzyme of RNAP (β, β’,
αI, αII, ω) to complete the holoenzyme. σ factors play a critical role in various stages of
transcription initiation that includes recognition of specific promoter elements,
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stabilization of the open complex, and activation of RNA synthesis. In E. coli, there are
two distinct families, the primary σ factor, σ 70, is responsible for the bulk of
transcription during growth of cells consisting of 4 conserved regions (1-4). Each region
has their own distinct function. Region 1 contains primary σ factors. Regions 2, 3, and 4
interact with elements of the promoter –10 and –35 on RNAP (Paget, 2015). Region 2
interacts with the β’ clamp helices, also called the β' coiled-coil, forming the holoenzyme.
Region 4 interacts with the β flap domain of RNAP (Banta et al., 2013). The other
family, σ 54, requires ATP hydrolysis to aid in the melting of DNA to direct transcription
(Paget, 2015). σ S is turned on when there are environmental stresses (Banta et al., 2013).
Transcription Cycle
Transcription is regulated in 3 stages; initiation, elongation, and termination. The
synthesis of RNA is initiated at the promoter sequence by RNAP. The formation of the
RNAP holoenzyme designated by a specific σ factor causes a closed complex. A
transcription bubble will form allowing nucleotide triphosphates to bind. DNA is melted
exposing the transcription start site, forming the open complex. RNAP directs the
synthesis of short abortive transcripts before escaping into productive elongation
(Zlatanova & van Holde, 2015). During elongation, the transcription complex may
encounter pause sites and potential arrest sites at which the nascent RNA remains bound
to the enzyme. Finally, upon reaching a termination sequence, RNAP releases the RNA
transcript and dissociates from the DNA (Leibman & Hochschild, 2007).
Transcription Factors
Transcriptional initiation is a crucial component for gene expression to occur. It is
regulated by several factors including DNA sequences, proteins, and small molecules.
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Initiation begins by the recruitment of the RNAP holoenzyme to a specific promoter
upstream of a particular gene. The σ factor, a domain of RNAP, is responsible for
specific promoter recognition guiding the holoenzyme to the promoter to initiate
transcription. Several σ factors compete to bind to RNAP depending on environmental
triggers and this sigma factor switching is responsible for differential expression.
Transcription factors (TFs), another important bacterial regulator can activate or
represses genes (Seshasayee et al., 2011). TFs can be classified into 3 types:
I.

TFs that influence the formation of the holoenzyme- Holoenzyme
formation is not only controlled by σ factor concentrations, but also
controlled by other proteins that guide σs to associate with RNAP. Anti σfactors regulate this process and also function to block particular σcontaining holoenzyme by binding directly to σ factor blocking regions 2
and/or 4 from making direct contact with their cognate RNAP binding
determinants (Paget, 2015).

II.

DNA-dependent TFs- These TFs activate or repress transcription initiation
in a DNA-dependent manner. TF activators bind to specific recognition
sites located upstream of a promoter, making direct contact with one or
more regions of RNAP. These regions of RNAP contacted in this manner
are usually the α-CTD or σ region 4 and stabilize the initial binding of
RNAP to the promoter. TF repressors function by binding to the promoter
region and blocking RNAP from binding, inhibiting transcription
(Feklístov et al., 2014).
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III.

DNA-independent TFs- TFs in E. coli such as Gre factors (GreA and
GreB) and DksA can access RNAP without contacting DNA, influencing
transcription at all stages of the transcription cycle. These factors affect
specific kinetic pathways to the open complex formation regulating RNA
output from specific promoters. For example, during elongation, Gre
factors are present when RNAP undergoes a process called backtracking.
This occurs when RNA 3′ end is no longer aligned with the active site
(Haugen et al., 2008). Endonucleolytic cleavage is catalyzed by the active
site and is greatly enhanced in the presence of Gre factors. The transcript
cleavage Gre factors contain a C-terminal globular domain that binds to
the entrance of the secondary channel and an N-terminal anti-parallel
coiled-coil domain that extends into the channel. The tip is positioned near
the displaced 3’ end of the RNA (Deighan & Hochschild, 2006). An
endonucleolytic cleavage reaction is stimulated re-aligning the 3' end of
the RNA in correct register with the enzyme’s active site facilitating
promoter escape (Lang et al., 2004).

Disruption of TF Interactions as Potential Therapeutic Strategies
With a rise in antibiotic resistance, the development of new therapeutic strategies
is required to combat infection. Microbial resistance is inevitable and has been
complicating treatments in most bacterial infections for years. Currently, antibiotics
target a small number of essential processes such as inhibition of cell wall synthesis,
DNA replication, RNA transcription, protein synthesis, and folate synthesis. Virulence
gene expression in vivo represents a potential target for antibiotic discovery that has not
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yet been fully explored. (Hung et al., 2005). Blocking the function of virulence factors
could limit pathogen colonization, damage to host cells, and aid the host immune system
in successful elimination of the pathogen.
In Vibrio cholerae, a high-throughput screen of a 50,000-compound small
molecule library from Chembridge Research Laboratories (Microformats) was used to
identify inhibitors of virulence factor expression. Fifteen compounds were identified and
had bacterial inhibitory function with minimal human cell toxicity. Virstatin, 1 of the 15
compounds, was selected for further study. To confirm inhibitory functions, under in
vitro virulence-inducing conditions, cholera toxin (CT) production, one of the major
virulence factors in V. cholerae, was undetectable in the presence of virstatin. Toxin
coregulated pilus (TCP) is coregulated with CT so virstatin’s ability to inhibit the
expression and function of TCP was also measured (Hung et al., 2005).
TCP is thought to play a role in early attachment to intestinal epithelium and is
required for intestinal colonization in an infant mouse model of cholera. Virstatin was
found to inhibit the transcriptional regulator ToxT, preventing the expression of CT and
TCP, protecting infant mice from intestinal colonization by V. cholerae. These results
demonstrate that drugs such as virstatin can be used, like conventional antibiotics, to treat
bacterial infections (Hung et al., 2005). Other small molecule inhibitors of virulence
regulation have been reported, including inhibitors of a two-component regulator of
alginate synthesis in P. aeruginosa and inhibitors of quorum sensing in Staphylococcus
aureus and P. aeruginosa. The bacterial two-hybrid assay was used to understand how
virstatin works. Identifying inhibitors of virulence factors represent another way to target
bacterial pathogens (Hung et al., 2005).
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Patients suffering from cystic fibrosis (CF) have an increased chance of having P.
aeruginosa infections. P. aeruginosa infections can produce copious amounts of the
exopolysaccharide alginate contributing to pathogenesis. Alginate prevents phagocytosis
and inhibits neutralization/opsonization by antibodies. Expression of alginate genes in P.
aeruginosa are regulated by several proteins and a two-component system. These
regulatory proteins are AlgR1 and AlgR2. AlgR1 binds to DNA and activates gene
expression of alginate and AlgR2 is a kinase that phosphorylates AlgR1. Twenty five
thousand synthetic compounds were screened and 15 were identified as inhibitors of algD
transcription in vivo in whole cells (Roychoudhury et al., 1993). This is important
because algD is a tightly regulated gene encoding GDP-mannose dehydrogenase, which
is critical for P. aeruginosa alginate biosynthesis (Wozniak & Ohman, 1994).
These 15 compounds were also found to inhibit alginate synthesis to some degree.
Two types of inhibitors on the effects of AlgR1 and AlgR2 were further investigated. The
inhibitory effect of these compounds on the known kinases of other two-component
systems was also examined. Out of the 15 inhibitory compounds, 4 of these were
identified to inhibit or repress the activation of the algD promoter in vivo. These
inhibitors could lead to the correlation of the phosphorylation/dephosphorylation of the
AlgR2-AlgR1 complex and the DNA-binding activity of AlgR1 with their physiological
roles in regulating alginate gene expression in P. aeruginosa. The overall goal is to
develop non-toxic inhibitors that target signal transduction pathways in genes associated
with virulence (Roychoudhury et al., 1993).
A study performed by Turner et al., 2014 used new technologies including
RNASeq and TnSeq to explore what P. aeruginosa genes are essential for acute and
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chronic infections in murine models. RNASeq allows quantitation of transcript levels and
TnSeq reports on the contribution of specific genes toward fitness in vivo. Remarkably,
the RNASeq analysis revealed that cues sensed by the bacteria in both types of infections
are similar. Transcripts encoding known virulence factors were being expressed such as
proteases, pyochelin, and rhamnolipids synthesis. These virulence factors were strongly
upregulated in both acute and chronic infections. However, psl biosynthetic genes were
strongly downregulated. Psl polysaccharide is the main matrix component in P.
aeruginosa biofilms. This was a surprising find because biofilms are thought to be
associated with the development of chronic infections (Crousilles et al., 2015).
TnSeq analysis revealed even more interesting findings. The type III and VI
secretion systems were found to be important for chronic infections, but not acute
infections. This was a surprising find because laboratory experiments have shown in vitro
that the type III secretion is thought to be associated with acute infections whereas the
type VI secretion systems are thought to be associated with chronic infections. P.
aeruginosa was previously thought to be highly dependent on amino acids due to the
abundance of proteases encoded in its genome. RNASeq analysis in Turner et al., 2014
found that P. aeruginosa is particularly partial to long-chain fatty acids. It was found that
enzymes involved in fatty acid metabolism are required for survival in acute and chronic
murine infection models (Crousilles et al., 2015).
The glyoxylate shunt pathway allows cells to utilize simple carbon compounds as
a carbon source when complex sources such as glucose are not available. It was found
that transcripts encoding enzymes involved in the oxidative decarboxylation steps of the
tricarboxylic acid (TCA) cycle were downregulated. The transcript encoding the first
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enzyme of the glyoxylate shunt (aceA) was upregulated. Previous studies have noted the
importance of the glyoxylate shunt pathway. Fahnoe et al., 2012 inactivated both aceA
and glcB in P. aeruginosa causing the glyoxylate shunt pathway to be completely
inactivated. The double mutant was completely cleared by 48-hour post-infection in a
mouse pulmonary infection model indicating that the shunt is essential for colonization in
vivo. It is hopeful that with newly emerging evidence of genes activated during acute and
chronic infections new antipseudomonal compounds might be discovered. Developing
inhibitors for fatty acid metabolism or the glyoxylate shunt pathway could be an avenue
of antimicrobial design however; this may be more difficult to design inhibitors because
humans have similar pathways/enzymes (Crousilles et al., 2015).
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EXPERIMENTAL DESIGN

Experimental Design Outline
Given that RNAP is highly conserved between E. coli and P. aeruginosa, the E.
coli RNAP coreome can be used to study RNAP-protein interactions in P. aeruginosa.
This assay could be used as a platform in the future to identify TFs from P. aeruginosa
that interact with RNAP. Proteins that modulate RNAP activity could be used as targets
for novel anti-pseudomonal drugs.
RNAP coreome
It is important to note that the bacterial two-hybrid assay used in this study
utilized elements of E. coli RNAP to determine interactions with P. aeruginosa proteins.
Although E. coli and P. aeruginosa thrive in different environments; E. coli typically
lives in the gut of humans and P. aeruginosa thrives in immune compromised individuals
and moist environments, they belong to the same class of bacteria
(Gammaproteobacteria). In general, RNAP is a highly conserved enzyme among bacteria.
Alignments of the amino acids of each piece of the E. coli RNAP coreome to specific
domains of P. aeruginosa RNAP have shown a high degree of similarity and are
represented in Table 2. Actual amino acid alignments are in Appendix A. The five
subunits of RNAP were broke down into 38 surface exposed independently folded
fragments. These regions were chosen based on crystal structure and biochemical
analysis. Each fragment was individually cloned in frame with the gene encoding the λcI
DNA binding protein in plasmid pAC-cI. The result was a pAC-λcI-RNAP coreome
plasmid library capable of expressing 38 different λcI-RNAP protein fusions.
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Table 2: Similarity of E. coli RNAP fragment in the coreome with the corresponding P.
aeruginosa RNAP fragments utilizing pBLAST.
E. coli RNAP
fragment
α 2-235
α 249-329
β 1-151
β 1-235
β’ 25-104
β’ 114-190
β’ 140-235
β 151-451
β’ 193-230
β 235-650
β’ 249-328
β’ 264-308
β’ 370-416
β 450-530
β’ 516-573
β 528-589
β 528-656
β’ 576-634
β 587-656
β’ 648-701
β 650-950
β 665-798
β 703-795
β’ 735-790
β’ 820-882
β 829-930
β 831-1059
β 930-1059
β’ 944-1021
β’ 944-1133
β 950-1342
β’ 1023-1128
β 1137-1226
β’ 1137-1243
β’ 1154-1212
β’ 1261-1307
σ 94-448
σ 528-613

E. coli Fragment
Length in Amino
Acids
233
80
150
234
80
76
96
300
37
415
80
45
46
80
57
61
128
58
69
53
300
133
92
55
62
101
228
129
52
189
392
105
89
106
58
46
354
85
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% similarity to
P. aeruginosa
82
99
88
89
96
92
86
85
84
86
100
100
94
92
91
93
88
83
83
83
92
87
92
100
90
93
82
75
78
81
87
82
85
93
93
84
84
93

Controls
To test the hypothesis that an E. coli RNAP coreome could be used to study
interactions with P. aeruginosa proteins, a series of positive control experiments were
designed. These positive control experiments were based on the limited studies of RNAPprotein interaction in P. aeruginosa. The P. aeruginosa protein, AlgQ, is known to
interact with regions 2 and 4 of σ70 of P. aeruginosa RNAP (Yuan et al., 2008). We
hypothesize that in a coreome assay AlgQ should interact with the represented regions 2
and 4 of σ70.
The NusG TF has been shown in E. coli to interact with RNAP β’ clamp helices
(Burmann et al., 2010). Utilizing bioinformatics analysis, a NusG homolog was found in
P. aeruginosa and was selected as a control. We hypothesize that P. aeruginosa NusG
should interact with the RNAP β’ clamp helices elements of the E. coli RNAP coreome
in the same manner. Based on Table 2, there are some subtle differences in P. aeruginosa
RNAP compared to E. coli RNAP. However, due to the high degree of similarity of the
RNAP in these organisms, it is reasonable to suspect P. aeruginosa proteins will interact
in a similar fashion with the E. coli RNAP.
Selecting potential P. aeruginosa protein targets for RNAP interactions
E. coli proteins that have been shown to either directly or indirectly interact with
RNAP are listed in Table 1. The list was downloaded from the IntAct Molecular
Interaction Database-www.ebi.ac.uk/intact. IntAct provides an open source database
system and analysis tools for molecular interaction data. All protein interactions are
derived from literature curation or direct user submissions and are freely available.
Because E. coli and P. aeruginosa are in the same class of bacteria, it is possible that
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these proteins could be functioning as TFs in both organisms. Compared to E. coli, much
less is known about the TFs in P. aeruginosa and how they (and other proteins) interact
with RNAP. Utilizing bioinformatic analysis, homologs to these E. coli proteins were
identified in P. aeruginosa.
Initially, sixteen P. aeruginosa homologs were selected for further analysis in the
bacterial two-hybrid assay to identify potential interactions with RNAP (see Table 1).
Sixteen potential target P. aeruginosa TF genes were cloned into the pBRα plasmid
expression vector that created fusions of the target proteins to the α-subunit of RNAP.
Expression of the target TF fusion proteins were under the control of an IPTG inducible
promoter. The RNAP coreome was fused to λcI. Expression of the RNAP coreome fusion
proteins were also under the control of an IPTG inducible promoter. Both bait and prey
plasmids were transformed into a β-galactosidase reporter strain FW102 OL2-62. The 16
P. aeruginosa proteins were tested against each member of the RNAP coreome library in
a 96 well format. Any proteins that directly interacted with a piece of the RNAP coreome
were then further investigated.
Validation of target protein interactions with RNAP coreome
Initially 16 P. aeruginosa proteins were screened in the bacterial two-hybrid
assay, 3 were shown to interact with fragments of RNAP. These 3 proteins were chosen
for further analysis. If an interaction between a P. aeruginosa protein and RNAP were
real, then it would be predicted that increasing the amount of the interacting proteins
would result in higher β-gal activity in the reporter strain. Liquid β-gal assays were then
performed with the reporter strain transformed with a plasmid expressing a specific P.
aeruginosa protein and a plasmid expressing a specific piece of the RNAP coreome.
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The transformed reporter strains were then grown in liquid broth media with
increasing amounts of IPTG. Another validation test was performing the bacterial twohybrid assay in the other orientation whereby fusing the P. aeruginosa protein of interest
to cI while the interacting piece of the RNAP coreome was fused to the α-subunit of
RNAP. If the interaction between the two proteins are real, then the prediction would be
that the orientation of the fusion proteins should not matter.
Analysis of P. aeruginosa Tig with the RNAP coreome.
Out of 3-potential P. aeruginosa proteins that were shown to interact with RNAP,
one was chosen for additional study. Further investigation focused on the protein Tig. In
the two-hybrid assay, Tig had the strongest interaction with RNAP. Tig is also a wellcategorized chaperone protein with a defined domain structure (Hoffmann et al., 2010).
Previous results in this work showed that Tig interacted with pieces of RNAP. However,
the sites of interaction between Tig and RNAP were not known. To determine the surface
of interaction between Tig and RNAP, Tig was spilt into its 3 domains. Each domain was
tested in the bacterial two-hybrid assay to determine a site of interaction with RNAP.
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METHODS

Bacterial Strains and Plasmids:
Table 3: A list of the bacterial strains and plasmids used in the study.
Strains
Function/cell genotype Antibiotic
Reference
Resistance
Markers
DH5α
E. coli host strain for
Kanamycin
Yuan et al., 2008
plasmid construction
FW102 OL2-62
FW102 harboring an F′ Kanamycin
Deaconescu et al.
Kan bearing test
2006
promoter placOL2-62
linked to lacZ
Plasmids
RNAP coreome
PlacUV5-directed
Chloramphenicol Supplied by:
resource
synthesis of the λcI
Padraig Deighan,
protein fused via three
Emmanuel College
alanines to 38 different
RNAP fragments. See
Table 2 for full details
of the RNAP fragments
pACλcI
IPTG inducible
Chloramphenicol Dove et al., 1997
expression of λcI
protein
pACλcI-βflap
PlacUV5-directed
Chloramphenicol Supplied by:
synthesis of the λcI
Padraig Deighan,
protein fused via three
Emmanuel College
alanines to residues
831-1057 of the β
subunit of E. coli RNAP
pACλcI-ClpA
IPTG inducible
Chloramphenicol This study
expression of λcI-ClpA
fusion protein
pACλcI-DppF
IPTG inducible
Chloramphenicol This study
expression of λcI-DppF
fusion protein
pACλcI-Tig
IPTG inducible
Chloramphenicol This study
expression of λcI-Tig
fusion protein
pBRα
IPTG inducible
Carbenicillin
Dove et al., 1997
expression of RNAP αsubunit
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pBRα-β flap

pBRα-β' 735-790
pBRα-β 450-530

pBRα-β 829-930

pBRα-β 831-1059
pBRα-β' 114-190
pBRα-β 11371226
pBRα-σ70 region
4

pBRα-AlgQ
pBRα-AtpD
pBRα-ClpA

Expression of RNAP
alpha NTD fused to E.
coli RNAP subunit beta,
aa 831-1057 (β-flap).
Can be cut with NotI
and BamHI to replace
β-flap with a moiety of
interest.
IPTG inducible
expression of RNAPα-β'
735-790 fusion protein
IPTG inducible
expression of RNAPα-β
450-530 fusion protein
IPTG inducible
expression of RNAPα-β
829-930 fusion protein
IPTG inducible
expression of RNAPα-β
831-1059 fusion protein
IPTG inducible
expression of RNAPα-β'
114-190 fusion protein
IPTG inducible
expression of RNAPα-β
1137-1226 fusion
protein
PlacUV5/Plpp- directed
synthesis of the αNTD
protein fused via three
alanines to E. coli σ70
region 4 (residues 528613 of σ70). The σ70
moiety also carries the
D581G substitution
IPTG inducible
expression of RNAPαAlgQ fusion protein
IPTG inducible
expression of RNAPαAtpD fusion protein
IPTG inducible
expression of RNAPαClpA fusion protein
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Carbenicillin

Supplied by:
Padraig Deighan,
Emmanuel College

Carbenicillin

Supplied by:
Padraig Deighan,
Emmanuel College
Supplied by:
Padraig Deighan,
Emmanuel College
Supplied by:
Padraig Deighan,
Emmanuel College
Supplied by:
Padraig Deighan,
Emmanuel College
Supplied by:
Padraig Deighan,
Emmanuel College
Supplied by:
Padraig Deighan,
Emmanuel College

Carbenicillin

Carbenicillin

Carbenicillin

Carbenicillin

Carbenicillin

Carbenicillin

Supplied by:
Padraig Deighan,
Emmanuel College

Carbenicillin

Yuan et al., 2008

Carbenicillin

This study

Carbenicillin

This study

pBRα-ClpB
pBRα-DppF
pBRα-GcvP
pBRα-Lon
pBRα-NusG
pBRα-PstB
pBRα-PyrG
pBRα-RhlE
pBRα-SdhA
pBRα-SpoT
pBRα-SutA
pBRα-Tig
pBRα-Tig
Domain 1
pBRα-Tig
Domains 1+2
pBRα-Tig
Domain 2

IPTG inducible
expression of RNAPαClpB fusion protein
IPTG inducible
expression of RNAPαDppF fusion protein
IPTG inducible
expression of RNAPαGcvP fusion protein
IPTG inducible
expression of RNAPαLon fusion protein
IPTG inducible
expression of RNAPαNusG fusion protein
IPTG inducible
expression of RNAPαPstB fusion protein
IPTG inducible
expression of RNAPαPyrG fusion protein
IPTG inducible
expression of RNAPαRhlE fusion protein
IPTG inducible
expression of RNAPαSdhA fusion protein
IPTG inducible
expression of RNAPαSpoT fusion protein
IPTG inducible
expression of RNAPαSutA fusion protein
IPTG inducible
expression of RNAPαTig fusion protein
IPTG inducible
expression of RNAPαTig domain 1 fusion
protein
IPTG inducible
expression of RNAPαTig domain 1+2 fusion
protein
IPTG inducible
expression of RNAPα32

Carbenicillin

This study

Carbenicillin

This study

Carbenicillin

This study

Carbenicillin

This study

Carbenicillin

This study

Carbenicillin

This study

Carbenicillin

This study

Carbenicillin

This study

Carbenicillin

This study

Carbenicillin
This study
Carbenicillin

This study

Carbenicillin

This study

Carbenicillin

This study

Carbenicillin

This study

Carbenicillin

This study

pBRα-Tig
Domains 2+3
pBRα-Tig
Domain 3
pBRα-TsaD

Tig domain 2 fusion
protein
IPTG inducible
expression of RNAPαTig domain 2+3 fusion
protein
IPTG inducible
expression of RNAPαTig domain 3 fusion
protein
IPTG inducible
expression of RNAPαTsaD fusion protein

Carbenicillin

This study

Carbenicillin

This study

Carbenicillin

This study

Media:
LB agar was made by adding 12.5 g of LB broth powder (VWR) supplemented with 7.5 g
of agar (VWR) per 500 mL of water. LB broth was made my adding 12.5 g of LB broth
powder (VWR) per 500 mL of water. LB-2X broth was made by adding 25 g of LB broth
(VWR) per 500 mL of water. When antibiotic selection was required, the appropriate
media was supplemented with 25 µg/mL of chloramphenicol for pAC-cI plasmids, and
100 µg/mL carbenicillin for pBRα plasmids. DH5α were selected for with 50 µg/mL
kanamycin. For the bacterial two-hybrid assay FW102 OL2-62 cells harboring the pACcI and pBRα plasmid, were selected for with 50 µg/mL kanamycin, 25 µg/mL
chloramphenicol, and 100 µg/mL carbenicillin.
Competent Bacterial Cells:
Chemically competent cells of DH5α and FW102 OL2-62 were made using the protocol
described in Dove et al., 1997.
Transformation of Plasmid DNA into E. coli DH5α Cells
To transform plasmid DNA into E. coli DH5α cells, the DH5α competent cells were
thawed on ice. One hundred microliters of cells were added to a sterile microcentrifuge
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tube and placed on ice. One microliter of desired plasmid was then added to the
competent cells, and incubated on ice for 30 minutes. After 30 minutes cells were heatshocked at 42 °C for 2 minutes and then placed back on ice for 2 minutes. One milliliter
of LB was then added to each centrifuge tube and incubated at 37 °C for 1 hour. One
hundred microliters of the transformation was then plated on LB media containing
appropriate antibiotics. Plates were incubated at 37 °C overnight.
Plasmid DNA Isolation:
Overnight cultures were made by inoculating one colony into LB broth media with
appropriate antibiotics. Following growth, the cells (7 mL) were pelleted at 4,000 g for
10 minutes at 4 °C. Plasmid preparations were then performed by the E.Z.N.A Plasmid
DNA Mini Kit I (OMEGA) using the manufacture’s protocol.
Cloning Genes into the Bacterial Two-Hybrid Plasmids: Primers and PCR
Primers were designed using DNA analysis software (a plasmid editor, ApE). Primers
were ordered that added a 5’-NotI site (GCGGGCCG, and an extra nucleotide to keep the
coding region in-fame) and 3’-BamHI site (GGATCC) flanking the gene of interest. PCR
was utilized to amplify the target gene with the added restriction sites. The forward
primer for cloning by PCR had the sequence 5'-gaagGCGGCCGC-followed by the start
codon of the gene of interest and approximately 17 additional nucleotides. The
nucleotides in lower case are terminal nucleotides that function as a binding site for the
restriction endonucleases. The reverse primer for cloning by PCR had the sequence 5'gaagGGATCC. The reverse primer incorporated approximately 17 nucleotides upstream
of the stop codon of the gene of interest, the stop codon, and a BamHI recognition site
GGATCCatat (BstYI or BglII are also compatible and can be cloned into BamHI-digested
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pACλcI-β-flap or pBRα-β flap backbones). NotI is a 8bp cutter 5'-GCGGCCGC-3'. Since
the protein of interest is going to be on the C-ter of the fusion proteins adding an extra
base onto the NotI site to maintain the reading frame (e.g., ‘A’). This new NotI site,
GCGGCCGCA, is translated into a 3 x Alanine linker. All primers were ordered form
Integrated DNA Technologies.
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Table 4: Table of forward and reverse primers used in PCR. The bolded letters indicate
restriction sites. The underline nucleotides are the terminal nucleotides added to provide a
binding site for the restriction endonucleases.
Gene of
Forward Primer
Reverse Primer
Interest
atpD
gaaggcggccgcaATGAGTAGCGGACG cttcggatccTTACAGTTTTTTGG
TATCG
CTTTCTCG
clpA
gaaggcggccgcaATGTTGAATCGAGA cttcagatctTCAGGCGGGCTCC
GCTCG
GCCGCCG
clpB
dppF
gcvP
Lon
nusG
(control)
pstB
pyrG
rhlE
sdhA
Spot
sutA
(control)

gaaggcggccgcaATGCGAATAGACCG
TTTG
gaaggcggccgcaATGGAAACCGTTCT
GACCG
gaaggcggccgcaATGTCGCAGACGCC
GTCCC
gaaggcggccgcaATGAAAACACTCGT
CG
atatgcggccgCAGTGGCTAAGCGTTG
GTACG
gaaggcggccgcaATGCAAAACGAGAC
CGCC
gaaggcggccgcaATGACGCGCTACAT
CTTCG
gaaggcggccgcaATGTCCTTTTCTTCC
CTCG
gaaggcggccgcaATGGCTAGCATTCG
TAC
gaaggcggccgcaTTGCCGGGCATAGA
CGCC
gaaggcggccgcaATGAGCGAAGAAGA
ACTG

cttcggatccTCAGGCGAAGACG
ATCTCGTCG
cttcggatccTCAGCCGAGGAAT
TGCTCGGCG
cttcggatccTCACTCGCGGTAG
TCGTCCAGC
cttcagatctCTAATGCGTGCTA
ATTCGCTC
atatagatcTTTAGACCTTTTCG
ACCTGACTG
cttcggatccCTAGCCGTAGCGG
CCGGTGATG
cttcggatccTCAGGCCTTCCCG
GAATATTTC
cttcggatccTTAGCGGTTGCGG
GTCAGCAG
cttcggatccTTAGTAAGTCCGA
ACCTTGGG
cttcggatccTCAGCTACGCAGG
CGGGTG
cttcggatccTCAGATGGGGCGG
CTGCCGTAC

tig

gaaggcggccgcaATGCAAGTTTCTGTT cttcggatccTCAGGCCGCTTGC
GAAAG
GGAGCTTCG

tig
domain
1
tig
domain
2

gaaggcggccgcaATGCAAGTTTCTGTT cttcggatccTCATTCGAAACGG
GAAAG
GTGTTCTGCTTGCG
atatgcggccgcacGTTTCGAAGTAGTC
GAGCG
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atatggatccTCAGTTCAGTTCCG
GCAGCTTGG

tig
domain
3
tig
domain
1+2
tig
domain
2+3
tsaD

gaaggcggccgcaAAGCTGCCGGAACT
GAACGAAGAG

cttcggatccTCAGGCCGCTTGC
GGAGCTTCG

gaaggcggccgcaATGCAAGTTTCTGTT atatggatccTCAGTTCAGTTCCG
GAAAG
GCAGCTTGG
atatgcggccgcaCGTTTCGAAGTAGTC
GAGCG

cttcggatccTACGGCCGCTTGC
GGAGCTTCG

gaaggcggccgcaATGCGCGTGCTGGG
ACTG

cttcggatccTCAGACCGCCGGC
AGCGACTC

PCR:
PCR was performed using a KOD extreme kit (Novagen) in a 100 µL reaction mix. The
reaction mix included 50 µL of 2X Xtreme buffer, 20 µL of 2 mM dNTPs, 3 µL of
forward and reverse primers at 10 mM, 10 µL of PAO1 Pseudomonas aeruginosa
chromosomal DNA (approximately 10 nanograms), 12 µL of water, and 2 µL of KOD
extreme Hot Start DNA polymerase.
PCR Reaction Conditions:
Step 1: 94 °C for 2 minutes
Step 2: 98 °C for 15 seconds
Step 3. 56 °C for 30 seconds. Annealing temperature is dependent on amplicon, see Table
5.
Step 4. 68 °C for 1 minute. Extension time is dependent on amplicon, see Table 5.
Step 5. go to step 2, repeat 28 times
Step 6. 68 °C 5 minutes
Step 7. 4 °C hold
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Table 5: Table of the annealing temperature and extension time of each amplicon.
Targets
algQ (control)

Annealing Temperature
(°C)
(Yuan et al., 2008)

Extension Time
(minutes)
(Yuan et al., 2008)

atpD

59

1

clpA

66

2.5

clpB

64

2.5

dppF

67

1

gcvP

66

3

Lon

58

2.5

nusG (control)

56

1

pstB

67

1

pyrG

62

1.75

rhlE

65

2

sdhA

60

2

Spot

66

2.25

sutA (control)

66

45 seconds

Tig

64

1.5

tsaD

68

1.25

PCR Clean-Up and DNA Gel Electrophoresis
PCR clean-up was performed by the Gel/PCR DNA Fragments Extraction Kit (IBI
SCIENTIFIC) using the manufactures protocol. Following PCR-clean up DNA was then
electrophoresed on a 1% agarose gel (VWR) to verify PCR amplification product size.
When needed, DNA was isolated from a gel slice using the Gel/PCR DNA Fragments
Extraction Kit (IBI SCIENTIFIC) using the manufactures protocol.
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Cloning protocol:
Construction of pBRα Expression Vectors
PCR products were digested with NotI and BamHI and ligated into pBRα expression
plasmid digested with NotI and BamHI. If the gene of interest contained an endogenous
BamHI site then the PCR product was digested with NotI and BglII. DNA digested with
BglII and BamHI leave complementary over hangs. This created plasmids that upon
induction with IPTG (GoldBio), lead to the production of proteins of interest fused to the
αNTD of RNAP.
Construction of pACλcI Expression Vectors
PCR products were digested with NotI and BamHI and ligated into the pACλcI
expression plasmid digested with NotI and BamHI. If the gene of interest contained an
endogenous BamHI site then the PCR product was digested with NotI and BglII. DNA
digested with BglII and BamHI leave complementary over hangs. This created plasmids
that upon induction with IPTG (GoldBio), lead to the production of proteins of interest
fused to the to the DNA binding domain of λcI.
Target Amplicon Digestion
The 30 µL digestion reaction mix included 15 µL of PCR product from the target gene of
interest, 1 µL of NotI and BamHI, 3 µL of CutSmart buffer 10X concentrate, and 10 µL
of water. For genes that had an endogenous BamHI site, cloning was performed with
BglII. The 30 µL digestion reaction mix included 15 µL of PCR product from the target
gene of interest, 1 µL of NotI and BglII or BamHI, 3 µL of buffer 3.1, and 10 µL of
water. All digestion reactions were incubated at 37 °C for one hour.
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Digestion of Plasmid Backbone pBRα β-flap and pACλcI
The 30 µL digestion reaction mix included 15 µL of pBR β-flap or pACλcI- β-flap, 1
µL of NotI and BamHI, 3 µL of CutSmart buffer 10X concentrate, and 10 µL of water.
All digestion reactions were incubated at 37 °C for one hour.
Ligation Protocol of Digested PCR Products into Plasmid Backbones
The 30 µL ligation reaction mix included 20 µL of NotI/BamHI–digested PCR product
from the gene of interest, 6 µL of NotI/BamHI–pBR β-flap or NotI/BamHI– pACλcI βflap, 3 µL 10X buffer for T4 DNA Ligase with 10mM ATP, and 1 µL of T4 DNA ligase
from New England Bio Labs. The ligation reactions were incubated at room temperature
for 15 minutes and then placed at 4 °C overnight.
DNA Sequencing
All plasmids generated in this study were sequenced (Genewiz Inc.) to verify that fusion
constructs were correct.
Screening for Potential Proteins that Interact with RNAP Coreome
We used a bacterial two-hybrid assay to identify the transcription factors-binding site on
RNAP for putative RNAP-associated proteins. The transcription factors were selected
based on data in the E. coli protein-protein interaction database (Table 1). From this list
of RNAP-associated proteins, we selected homologous proteins from P. aeruginosa that
had the highest degree of similarity with the E. coli proteins (Table 6).
Co-Transformation for a Coreome Assay
The reporter strain FW102 OL2-62 was co-transformed with each individual plasmid
from the coreome library and an expression plasmid containing a P. aeruginosa gene of
interest fused to α-subunit of RNAP. Four microliters of an expression plasmid
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containing a P. aeruginosa gene of interest were added to a microcentrifuge tube of
competent cells (reporter strain FW102 OL2-62). Sixteen microliters of competent cells
with gene of interest were added in a 96 well-plate that contained 39 different plasmids of
RNAP. The 40th well contained water for a negative control. The 96 well-plate was kept
on ice for 30 minutes and then heat shocked at 42 °C for 1 minute. The plate then sat on
ice for 5 minutes. One hundred microliters of 2X LB (VWR) were added to each well and
incubated for 1.5 hours. After incubation 120 µl of the co-transformation were added to a
new 96 well plate containing 600 µl LB broth (VWR) with 50 µg/mL kanamycin, 25
µg/mL chloramphenicol, and 100 µg/mL carbenicillin and 5 µM of IPTG. It was then
placed on a 96-well microplate shaker (VWR) at 900 rpm overnight at 37 °C. βgalactosidase assay to measure protein-protein interactions were done as described below
using a SpectraMAX plate reader (Molecular Devices).
Co-Transformation for β-Galactosidase Assay of Target and Known Interaction
One hundred microliters of competent cells (FW102 OL2-62) and 2 µl of the bait and
prey plasmids were added to a microcentrifuge tube. The microcentrifuge tube was kept
on ice for 30 minutes. After 30 minutes the microcentrifuge tube was heat shocked at 42
o

C for 1 minute and then kept on ice for 5 minutes. One milliliter of 2X LB nutrient broth

was then added to the microcentrifuge tube and incubated at 37 ºC for 1.5-2 hours. The
microcentfigue tube was then pipetted out in equal volumes in a 96 well-plate with 600 µl
of selective media broth containing 50 µg/mL kanamycin, 25 µg/mL chloramphenicol,
and 100 µg/mL carbenicillin with various concentrations of IPTG. The 96 well-plate was
then placed on a plate shaker (VWR Advanced Vortex Mixer) at 500 rpm overnight. β-
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galactosidase assays to measure protein-protein interactions were done as described
below.
β-Galactosidase Assays
β-galactosidase assays were performed with microtiters plates and a microtiter plate
reader (EPOCH/2 Microplate Reader SN 1410067) as described in Thibodeau et al.,
2004. The ortho-Nitrophenyl-β-galactosidase (ONPG) used was purchased from
GoldBio. In experiments performed in the presence of increasing IPTG, assays were
conducted 3 times in duplicate. Miller units were calculated as described in Thibodeau et
al., 2004.
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RESULTS AND DISCUSSION

RNAP Coreome
P. aeruginosa and E. coli are closely related, both belong to the class
Gammaproteobacteria. Twenty-two bacterial genomes of pooled ORFs were compared to
P. aeruginosa and the sequences were aligned using BLASTP44. It was found that nearly
half of the best hits above a stringent comparison threshold were to E. coli (Stover et al.,
2000). Half of the ORFs in E. coli therefore have homologs in P. aeruginosa. No other
organisms tested accounted for even 10%. Although closely related, P. aeruginosa has a
significantly larger genome resulting in greater genetic complexity (Stover et al., 2000).
The similarities of these two organisms should allow us to utilize elements of E. coli
RNAP, known as the RNAP coreome, to determine interactions with P. aeruginosa
proteins.
The RNAP coreome consist of 38 surface exposed regions of RNAP. The
coreome was constructed based on the high-resolution structure of the bacteria Thermus
aquaticus RNAP and alignments to E. coli RNAP. Results suggested that E. coli β RNAP
can be parsed into 10 sub-domains. Analysis of the E. coli β’ subunit of RNAP suggested
that it could be parsed into 18 sub-domains. To identify where a regulatory factor (or
other protein) binds to RNAP, experiments can be performed where the regulatory factor
of interest is fused to the α sub-domain of RNAP and activates transcription in the
presence of any RNAP sub-domain fused to the λcI domain (Nickels, 2009). In addition,
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the coreome contains two α pieces of RNAP, α 2-235 and α 249-325 which corresponds
to regions 2 and 4 of σ70.
A bacterial two-hybrid assay can be used to validate protein-protein interactions
between the regulatory factor of interest and a sub-domain of RNAP. It can also be used
to identify amino acid substitutions in the RNAP sub-domain or the regulatory factor that
specifically disrupts (or enhances) the protein–protein interaction (Nickels, 2009). In
general, RNAP is a highly conserved enzyme among bacteria. Alignments of the amino
acids of each piece of the E. coli RNAP coreome to specific domains of P. aeruginosa
RNAP have shown to have a high degree of similarity (Table 2). Based on the high
degree of similarity to the E. coli RNAP coreome we hypothesized that the E. coli RNAP
coreome could be utilized to study RNAP-interacting proteins in P. aeruginosa.
E. coli RNAP Coreome Interactions with P. aeruginosa Proteins Known to Interact
with RNAP.
P. aeruginosa protein AlgQ
To validate that the E. coli RNAP coreome is suitable to study P. aeruginosa
proteins, two well-studied TFs in P. aeruginosa were chosen that had previously
described interactions with RNAP. The P. aeruginosa protein, AlgQ, is known to interact
with regions 2 and 4 of σ70 of P. aeruginosa RNAP. AlgQ regulates the production of key
virulence factors such as alginate, and pyocyanin (Yuan et al., 2008). To test whether
AlgQ interacted with any pieces of the E. coli RNAP coreome, a bacterial two-hybrid
assay was used with an α-AlgQ fusion protein and λcI fusion proteins of the E. coli
RNAP coreome. The α-AlgQ fusion protein activated transcription from the test promoter
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in the presence of pAcI-σ 528-613 (σ70 R4) and had ~6-fold increase in β-galactosidase
activity compared to α-AlgQ + λcI control (Figure 7).
Within the σ 528-613 region of the E. coli RNAP coreome there was a 93%
similarity to the corresponding RNAP region of P. aeruginosa (Table 2). The α-AlgQ
fusion protein activated transcription from the test promoter in the presence of pAcI-α 2235 and had a ~3-fold increase in β-galactosidase activity compared to α-AlgQ + λcI
control. Within the α 2-235 region of the E. coli RNAP coreome there was an 82%
similarity found in the corresponding RNAP region of P. aeruginosa (Table 2). These
results indicated that α-AlgQ interacted with pAcI-α 2-235 and pAcI-σ 528-613 of the
RNAP coreome. The interaction between AlgQ and pAcI-σ 528-613 is what was
expected because AlgQ is known to interact with region 4 of σ70 of P. aeruginosa RNAP
(Yuan et al., 2008). In the E. coli RNAP coreome we only see an interaction with region
4. This is likely due to the fact that σ70 R4 of E. coli has a 93% similarity to the
corresponding RNAP region of P. aeruginosa compared to an 84% similarity in σ70 R2.
Slight differences in σ70 R2 between these two organisms could explain why an
interaction was not detected between AlgQ and E. coli σ70 R2.
pAcI-α 2-235 appears to be a sticky protein fragment that has been shown to
generate non-specific binding in a number of two-hybrid assays. Out of the 16 P.
aeruginosa proteins tested against the E. coli RNAP coreome, 5 interacted with pAcI-α 2235 R45A (Table 6). Any interactions with those domains were not further investigated.
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Figure 7: RNAP coreome screen displaying AlgQ interactions with RNAP-α 2235 R45A and σ 528-613 D581G. Diagram shows β-galactosidase transcription
activation of a bacterial two-hybrid assay. This assay depicts two interactions of
an α-fusion of AlgQ with cI-fusions of the RNAP coreome. The dashed line
indicates the average background level of β-galactosidase activity. pBRα and
pACλCI plasmids directed the synthesis of fusion proteins under the control of
IPTG-inducible promoters. The co-transformed FW102 OL2-62 reporter strain
was grown in the presence of 20 µM IPTG and then assayed for β-galactosidase
activity. β-galactosidase activity is expressed in Miller units indicated on the yaxis. The x-axis indicates the individual E. coli RNAP coreome fragments being
expressed in the reporter strain.

P. aeruginosa Protein NusG
NusG is a well-studied highly conserved TF that has been shown in E. coli to
interact with RNAP β’ clamp helices. NusG activates Rho transcription termination factor
in vitro and is necessary for most Rho-mediated termination events in vivo (Burmann et
al., 2010). NusG-NTD binds to RNAP and increases the rate of transcription elongation
but cannot stimulate termination (Burmann et al., 2010). In E. coli, NusG is an essential
bacterial regulator of the RNAP with a size of 20.5 kDa. NusG is a two-domain protein
that suppresses RNAP pausing and increases elongation rates in vitro (Burmann et al.,
2010).
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Utilizing bioinformatics analysis, a NusG homolog was found in P. aeruginosa.
To test whether Pseudomonas aeruginosa NusG interacted with any pieces of the E. coli
RNAP coreome, a bacterial two-hybrid assay was used with an α-NusG fusion protein
and λcI fusion protein of the RNAP coreome. The α-NusG fusion protein activated
transcription from the test promoter in the presence of pAcI-β’249-328, and had a ~2.5fold increase in β-galactosidase activity compared to α-NusG + λcI control. α-NusG
fusion protein also activated transcription from the test promoter in the presence of pAcIβ’264-308, and had a ~3-fold increase in β-galactosidase activity compared to α-NusG +
λcI control (Figure 8). β’249-328 and β’264-308 regions of the E. coli RNAP coreome
have 100% similarity in the corresponding RNAP region of P. aeruginosa and are
overlapping fragments (Table 2). These results indicated that P. aeruginosa α-NusG
interacted with pAcI-β’249-328 and pAcI-β’264-308 of the E. coli RNAP coreome which
is what would be predicted since it is known that E. coli NusG interacts with β’ clamp
helices (Burmann et al., 2010).
These control experiments with AlgQ and NusG suggest that the E. coli RNAP
coreome can be used to detect RNAP-interacting proteins in P. aeruginosa. It was
demonstrated that P. aeruginosa AlgQ and NusG interacted with the previously known
RNAP elements expressed in E. coli. Since P. aeruginosa AlgQ and NusG interacted as
predicted with elements of the E. coli RNAP coreome, 16 additional P. aeruginosa
protein targets that had previously undescribed interactions with RNAP in P. aeruginosa
were screened for interactions with the E. coli RNAP coreome.
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Figure 8: RNAP coreome screen demonstrating NusG interactions with β’249-328
and β’264-308. Diagram shows β-galactosidase transcription activation in a
bacterial two-hybrid assay. This assay depicts interaction of an α-fusion of P.
aeruginosa NusG with cI-fusion of the E. coli RNAP coreome. The dashed line
indicates the average background level of β-galactosidase activity. pBRα and
pACλCI plasmids directed the synthesis of fusion proteins under the control of
IPTG-inducible promoters. The co-transformed FW102 OL2-62 reporter strain
was grown in the presence of 20 µM IPTG and then assayed for β-galactosidase
activity. β-galactosidase activity is expressed in Miller units indicated on the yaxis. The x-axis indicates the individual E. coli RNAP coreome fragments being
expressed in the reporter strain.

Screening 16 P. aeruginosa Target Proteins with Previously Undescribed RNAP
Interactions for Interactions with the E. coli RNAP coreome.

A list of E. coli proteins were shown to be associated with RNAP. The
information was gathered from IntAct Molecular Interaction Databasewww.ebi.ac.uk/intact (Table1). A BLAST search was performed through
Pseudomonas.com to identify proteins from this E. coli list that had the highest similarity
(greater than 75%). P. aeruginosa proteins were chosen based on high similarity,
previously undescribed interaction with P. aeruginosa RNAP, and the lack of the NotI
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site. The NotI site was critical for cloning into the pBRα expression vector. These 16
genes were cloned into the pBRα expression plasmid.
Initially, 16 target P. aeruginosa proteins with fusions to the pBRα expression
vector were screened in the bacterial two-hybrid assay tested against the fusion of λcI of
the RNAP coreome. Upon testing target proteins against the RNAP coreome only 3
proteins had a direct interaction with RNAP. α-ClpA, α-DppF, and α-Tig all interacted
with RNAP. α-AtpD, α-ClpB, α-GcvP, α-Lon, α-PstB, α-PyrG, α-RhlE, α-SdhA, α-SpoT,
α-SutA, and α-TsaD had no significant interaction with the RNAP coreome. See
Appendix B for the bacterial two-hybrid assay data for those P. aeruginosa target
proteins that showed no interactions with the E. coli RNAP coreome.
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Table 6: Genes of interest that were inputted into the bacterial two-hybrid assay and
individually tested for interaction with each RNAP fragment in the E. coli RNAP
coreome library. The function for each protein and the percentage of homology to E. coli
homologs is listed. Information of protein function was downloaded from uniprothttp://www.uniprot.org/.
Gene of
Interest
algQ
(control)

Length of
Protein in
Amino
Acids
160

atpD

458

clpA

758

clpB

854

dppF

323

gcvP

958

Lon

798

Protein Function

% Identity

Alginate regulatory
protein. Activated in
conditions similar to
cystic fibrosis lungs.
ADP to ATP synthase in
the presence of a proton
gradient across the
membrane. Catalytic sites
primarily in the β-chain.
ATP-binding protease
component
Part of a stress-induced
multi-chaperone system
involved in the recovery
of cell from heat-induced
damage. DnaK, DnaJ, and
GrpE are also proteins
involved.
Dipeptide ABC
transporter ATP-binding
protein
Glycine dehydrogenase.
The glycine cleavage
system catalyzes the
degradation of glycine.
ATP-dependent serine
protease that mediates the
selective degradation of
mutant and abnormal
proteins as well as certain
short-lived regulatory
proteins. Required for
cellular homeostasis and
for survival from DNA
damage and
developmental changes
induced by stress.

Found only
in P.
aeruginosa
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Summary of RNAP
fragment
interactions found
in this study
α 2-235 R45A & σ
528-613 D581G

82

None determined

75

β 829-930 & β 8311059
None determined

76

71

β' 114-190 & β 11371226

74

None determined

72

None determined

nusG
(control)

177

pstB

277

pyrG

542

rhlE

639

sdhA

590

Spot

701

Participates in
transcription elongation,
termination and
antitermination.
Part of the ABC
transporter complex
PstSACB involved in
phosphate import.
Responsible for energy
coupling to the transport
system.
CTP synthase. Catalyzes
the ATP-dependent
amination of UTP to CTP
with either L-glutamine or
ammonia as the source of
nitrogen. Regulates
intracellular CTP levels
through interactions with
the four ribonucleotide
triphosphates.
DEAD-box RNA helicase
involved in ribosome
assembly. Has RNAdependent ATPase
activity and unwinds
double-stranded RNA.
Succinate dehydrogenase
(A subunit). This protein
is involved in step 1 of the
subpathway that
synthesizes fumarate from
succinate (bacterial route).
Guanosine-3',5'bis(diphosphate) 3'
pyrophosphohydrolase. In
eubacteria ppGpp
(guanosine 3'-diphosphate
5-' diphosphate) is a
mediator of the stringent
response that coordinates
a variety of cellular
activities in response to
changes in nutritional
abundance.
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73

β' 248-328 & β' 264308

80

None determined

75

None determined

73

α 2-235 R45A

75

α 2-235 R45A

73

None determined

sutA

105

Tig

436

tsaD

341

Transcription factor
expressed during slow
growth. Causes
widespread changes in
gene expression, and plays
a direct role in the
regulation of genes
encoding ribosomal
components. Associates
with chromosomal DNA
through interaction with
RNA polymerase.
Contributes to biofilm
formation and secondary
metabolite production.
Important during
transitions to and from the
survival state.
Trigger factor. Involved in
protein export. Acts as a
chaperone by maintaining
the newly synthesized
protein in an open
conformation. Functions
as a peptidyl-prolyl cistrans isomerase.
O-sialoglycoprotein
endopeptidase. Required
for the formation of a
threonylcarbamoyl group
on adenosine at position
37 (t6A37) in tRNAs that
read codons beginning
with adenine and plays a
direct catalytic role in this
reaction.

Found only
in P.
aeruginosa

α 2-235 R45A

76

β' 735-790 & β 450530

72

α 2-235 R45A

P. aeruginosa ClpA Interacts with RNAP β-flap, β 829-930 and β 831-1059
Caseinolytic proteases (Clp) is responsible for ATP-dependent degradation of
cytosolic proteins that are responsible for recognition, unfolding and cleavage of
substrate proteins into large peptides (Chandu & Nandi, 2004). Clps are barrel-shaped
ATP-dependent proteases consisting of two domains. One is a catalytic domain and the
other is regulatory domain. Clp regulators belong to the Clp/Hsp100 family of ATPases,
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Clp A, B, X and Y (HslU), and are structurally and functionally different. ClpA and ClpB
have two nucleotide binding domains. ClpB entirely acts as a chaperone protein whereas
ClpA and ClpX function as chaperones and also bind to ClpP to form the ATP-dependent
proteases ClpAP or ClpXP (Schirmer et al., 1996).
The α-ClpA fusion protein activated transcription from the test promoter in the
presence of pAcI-β 829-930 and had a ~2.5-fold increase in β-galactosidase activity
compared to α-ClpA + λcI control. α-ClpA fusion protein activated transcription from the
test promoter in the presence of pAcI-β 831-1059 and had a ~3-fold increase in βgalactosidase activity compared to α-ClpA + λcI control (Figure 9). Within region β 829930 of the E. coli RNAP there was a 93% similarity in the corresponding RNAP region
of P. aeruginosa. Within region β 831-1059 of the E. coli RNAP there was an 82%
similarity in the corresponding RNAP region of P. aeruginosa (Table 2). These two
regions are overlapping fragments of RNAP. These resulted indicated that α-ClpA
interacted with pAcI-β 829-930 and pAcI-β 831-1059 of the RNAP coreome which
corresponds to the β-flap domains of RNAP (Schirmer et al., 1996).
The β-flap domain has multiple roles in enhancer-dependent transcription.
Remarkably, it also appears to have different functions in enhancer-dependent and
independent transcription (Wigneshweraraj et al., 2003). β-flap is also known to bind to
sigma factors, specifically σ70 R2 and R4 that make simultaneous contact with promoter
elements. The interaction is required for sequence-specific interaction with the promoter 10 and a -35 element. It is possible that ClpA binds to RNAP as a chaperone or has some
role in RNAP-nucleotide interactions; however more investigation is needed to elucidate
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the role of ClpA-RNAP interaction. ClpA could also play a role in taking damaged or old
RNAP molecules to the ClpP protease for degradation.

Figure 9: RNAP coreome screen displaying ClpA interactions with RNAP-β 829930 & β 831-1059. Diagram shows β-galactosidase transcription activation of a
bacterial two-hybrid assay. This assay depicts two interactions of an α-fusion of
P. aeruginosa ClpA with cI-fusion of the E. coli RNAP coreome. The dashed line
indicates the average background level of β-galactosidase activity. pBRα and
pACλCI plasmids directed the synthesis of fusion proteins under the control of
IPTG-inducible promoters. The co-transformed FW102 OL2-62 reporter strain
was grown in the presence of 20 µM IPTG and then assayed for β-galactosidase
activity. β-galactosidase activity is expressed in Miller units indicated on the yaxis. The x-axis indicates the individual E. coli RNAP coreome fragments being
expressed in the reporter strain.
P. aeruginosa DppF Interacts with RNAP β’ clamp (β' 114-190) and β 1137-1226
DppF is a dipeptide inner membrane ATP-binding cassette transporter
(DppBCDF). Heme is a major iron source and the uptake through E. coli K12 requires a
permease made up of DppBCDF (the dipeptide inner membrane transporter) as the ABC
transporter and either MppA (L-alanyl -ɤ-D-glutamyl-meso-diaminopimelate binding
protein) or DppA (the dipeptide periplasmic protein) as the soluble periplasmic substratebinding protein (PBP) (Létoffé, Delepelaire, & Wandersman, 2006).
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α-DppF fusion protein activated transcription from the test promoter in the
presence of pAcI-β' 114-190 and had a ~5-fold increase in β-galactosidase activity
compared to α-DppF+ λcI control. α-DppF fusion protein activated transcription from the
test promoter in the presence of pAcI-β 1137-1226 and had a ~4.5-fold increase in βgalactosidase activity compared to α-DppF+ λcI control (Figure 10). Within region β'
114-190 of the E. coli RNAP there was a 92% similarity in the corresponding RNAP
region of P. aeruginosa. Within region β 1137-1226 of the E. coli RNAP there was a
85% similarity in the corresponding RNAP region of P. aeruginosa (Table 2). These
results indicated that α-DppF interacted with pAcI-β' 114-190 and pAcI-β 1137-1226 of
the RNAP coreome. The β’ 114-190 piece of the RNAP coreome is the N-terminal
domain and is part of the β’ clamp. Studies have found that σ70 adjacent to σ2 called the
non-conserved region (σ70 NCR) and β’ antagonize the σ2/β′ coiled-coil interaction.
Specifically, σ70 NCR/β’ interaction facilitates promoter escape and hinders early
elongation pausing (Leibman & Hochschild, 2007). Unfortunately, not much is known
about the function of the β 1137-1226 part of the β subunit of RNAP.
DppF interaction with RNAP is odd. One possibility is that the cytoplasmic side
of DppF might contain a domain similar to a domain found in other proteins that interact
with RNAP. It is interesting to note that both ClpA and DppF have ATPase domains. It is
possible that RNAP might have binding affinity for ATPase domains. If RNAP is
interacting with these proteins via their ATPase domains making ClpA/DppF α-fusions
that lack ATPase domains could be used in the bacterial two-hybrid assay. If RNAP is
interacting with these proteins via their ATPase domains, then ATPase mutants would be
predicted to have improved ability to activate transcription from the lacZ test promoter.
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Figure 10: RNAP coreome screen displays DppF interactions with RNAP-β’ 114190 and β 1137-1226. Diagram shows β-galactosidase transcription activation of a
bacterial two-hybrid assay. This assay depicts two interactions of an α-fusion of
P. aeruginosa DppF with cI-fusion of the E. coli RNAP coreome. The dashed line
indicates the average background level of β-galactosidase activity. pBRα and
pACλcI plasmids directed the synthesis of fusion proteins under the control of
IPTG-inducible promoters. The co-transformed FW102 OL2-62 reporter strain
was grown in the presence of 20 µM IPTG and then assayed for β-galactosidase
activity. β-galactosidase activity is expressed in Miller units indicated on the yaxis. The x-axis indicates the individual E. coli RNAP coreome fragments being
expressed in the reporter strain.
P. aeruginosa Tig Interacts with RNAP β' 735-790 and β 450-530
Molecular chaperones support protein folding in all living organisms. Chaperones
have various cellular roles including assisting in de novo folding, refolding of stressdenatured or aggregated proteins, assembly of oligomeric proteins, protein transport and
proteolytic degradation. Chaperone proteins can be constitutively expressed whereas
others are stress-induced. The trigger factor in E. coli is the only ribosome-associated
chaperone known in bacteria. Trigger factor is constitutively expressed and is an
abundant cytosolic protein that exists in a two- to three-fold molar excess relative to
ribosomes (Hoffmann et al., 2010). Trigger factor cooperates with two ATP-dependent
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chaperones, DnaK and GroEL, in de novo folding. Deletion of trigger factor encoding tig
has no effects on protein aggregation or obvious growth phenotype and is likely
compensated by enhanced action of DnaK and GroEL. However, in the absence of DnaK,
trigger factor become essential at certain growth conditions like high temperature stress.
Cells lacking dnaK are viable at intermediate growth temperatures, deletion of tig and
dnaK leads to lethality in cells grown above ~30°C (Hoffmann et al., 2010).
Trigger factor protein is 48kDa and consists of three domains (Figure 11). The
PPIase domain, the C-terminal domain and the N-terminal domain. The middle domain of
trigger factor protein has catalytic activity as a peptidyl-prolyl cis/trans isomerase
(PPIase). The C-terminal domain constitutes nearly half of the molecule and represents
the main chaperone module of trigger factor. The N-terminal domain is structurally
related to parts of the bacterial chaperone Hsp33, but carries an additional helix-loophelix element and has ribosome-binding chaperone activity. (Hoffmann et al., 2010).

Figure 11: Structural domains of the Trigger factor protein.
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The α-Tig fusion protein activated transcription from the test promoter in the
presence of pAcI-β' 735-790 and had an ~8-fold increase in β-galactosidase activity
compared to the α-Tig + λcI control. α-Tig fusion protein activated transcription from the
test promoter in the presence of pAcI-β 450-530 and had a ~12-fold increase in βgalactosidase activity compared to α-Tig + λcI control (Figure 12). Within region β' 735790 of the E. coli RNAP there was a 100% similarity in the corresponding RNAP region
of P. aeruginosa. Within region β 450-530 of the E. coli RNAP there was a 92%
similarity in the corresponding RNAP region of P. aeruginosa. These results indicate that
Tig interacted with β' 735-790 and β 450-530 of RNAP. Not much is known about the
function of these pieces of RNAP. However, work performed by Padraig Deighan
(Personal Communication) demonstrated that Tig in E. coli interacted with β 450-530,
one of the same pieces that P. aeruginosa Tig interacted with (Figure 13). Tig has known
chaperone activity on large protein complexes like ribosomes. Currently, no evidence has
been published indicating Tig has chaperone activity on RNAP. It could be possible that
Tig contacts β and β’ subunits of RNAP and aids in RNAP protein folding. Additional
experiments would be required to determine if Tig has chaperone activity on RNAP
activity.
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Figure 12: RNAP coreome screen displays P. aeruginosa Tig interactions with
RNAP-β’735-790 & β 450-530. Diagram shows β-galactosidase transcription
activation of a bacterial two-hybrid assay. This assay depicts two interactions of
an α-fusion of P. aeruginosa Tig with cI-fusion of the E. coli RNAP coreome.
The dashed line indicates the average background level of β-galactosidase
activity. pBRα and pACλcI plasmids directed the synthesis of fusion proteins
under the control of IPTG-inducible promoters. The co-transformed FW102 OL262 reporter strain was grown in the presence of 20 µM IPTG and then assayed for
β-galactosidase activity. β-galactosidase activity is expressed in Miller units
indicated on the y-axis. The x-axis indicates the individual E. coli RNAP coreome
fragments being expressed in the reporter strain.
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Figure 13: RNAP coreome screen displays E. coli Tig interactions with RNAP- β
450-530 and β 650-950. Diagram shows β-galactosidase transcription activation
of a bacterial two-hybrid assay. This assay depicts two interactions of an α-fusion
of E. coli Tig with cI-fusion of the E. coli RNAP coreome. The dashed line
indicates the average background level of β-galactosidase activity. pBRα and
pACλcI plasmids directed the synthesis of fusion proteins under the control of
IPTG-inducible promoters. The co-transformed FW102 OL2-62 reporter strain
was grown in the presence of 20 µM IPTG and then assayed for β-galactosidase
activity. β-galactosidase activity is expressed in Miller units indicated on the yaxis. The x-axis indicates the individual E. coli RNAP coreome fragments being
expressed in the reporter strain. Work performed by Padraig Deighan.

Studying the Strength of Interaction of Target P. aeruginosa proteins with RNAP
Additional bacterial two-hybrid experiments were performed with various
concentrations of IPTG. Results from these experiments can increase the understanding
of the strength of interaction between the P. aeruginosa proteins with pieces of the E. coli
RNAP coreome. Both the target P. aeruginosa proteins and the E. coli RNAP coreome
fragments are being expressed from IPTG inducible promoters. Adding increasing
amounts of IPTG would be predicted to cause increasing expression of the fusions
proteins in the bacterial two-hybrid assay. Increasing the expression of the interacting
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proteins should drive increased expression of β-galactosidase from the lacZ test promoter,
resulting in increasing Miller units as the amount of IPTG is increased.
ClpA Interaction with β-829-930
To study the strength of the interaction, α-ClpA was tested against the previously
shown two interacting pieces (β 829-930 and β 831-1059) of the RNAP coreome with
various concentrations of IPTG (Figure 14). α-ClpA + pAcI-β 829-930 had a background
value of 296 Miller units in the absence of IPTG, 624 Miller units when induced with 2
μM IPTG, 822 Miller units when induced with 10 μM IPTG, and 652 Miller units when
induced with 20 μM IPTG.
α-ClpA + pAcI-β 829-930 increased to 822 Miller units at 10 μM IPTG and then
decreased to 652 Miller units at 20 μM IPTG. A decrease in Miller units could be due to
the overexpression of these proteins in the cell that consume cellular resources that might
be needed for normal transcription/translation. Another possibility is that overexpressing
proteins that are interacting with RNAP could disrupt the normal function of RNAP in
the cell and disrupt normal transcription.
The negative control pBRα-ClpA + pAcI had a background value of 239 Miller
units in the absence of IPTG, 279 Miller Units when induced with 2 μM IPTG, 264
Miller units when induced with 10 μM IPTG, and 154 Miller units when induced with 20
μM IPTG. The negative control pBRα + pAcI-β 829-930 had a background value of 224
Miller units in the absence of IPTG, 242 Miller units when induced with 2 μM IPTG, 268
Miller units when induced with 10 μM IPTG, and 214 Miller units when induced with 20
μM IPTG. The negative controls have low amounts of Miller units because only one half
of the protein is being expressed. Within the bacterial two-hybrid assay there is no
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protein-protein interaction happening so β-galactosidase activity is really low. α-ClpA +
pAcI-β 829-930 had ~3.5-fold increase in β-galactosidase activity at 10 μM IPTG and a
~3-fold increase in β-galactosidase activity at 20 μM IPTG compared to the negative
controls suggesting that we do, in fact, have an interaction.
Previous studies have demonstrated that σ70 R4 strongly interacts with β-flap of
RNAP. We used pBRα -σ70 R4 + pAcI-βflap as a positive control and had a background
value of 546 Miller units in the absence of IPTG, 779 Miller units when induced with 2
μM IPTG, 1217 Miller units when induced with 10 μM IPTG, and 1350 Miller units
when induced with 20 μM IPTG. Increasing amounts of IPTG should result in increased
β-galactosidase production from the lacZ test promoter and this is demonstrated
indicating that the assay is functioning correctly.
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Figure 14: Results of bacterial two-hybrid assays performed with the FW102
OL2-62 E. coli reporter strain transformed with one plasmid that expresses a P.
aeruginosa α-ClpA fusion protein and a second plasmid expressing the β 829-930
cI-fusion of the E. coli RNAP coreome. The positive control was the reporter
strain transformed with a pBRα -σ70 R4 + pAcI-βflap. One negative control was
the reporter strain transformed with one plasmid expressing the α-ClpA fusion
protein and a second plasmid expressing λcI. A second negative control was the
reporter strain transformed with one plasmid expressing just the α protein and a
second plasmid expressing the β 829-930 cI-fusion. The plasmids directed the
synthesis of fusion proteins under the control of an IPTG-inducible promoters.
Reporters strains were grown in the absence or presence of 0, 2, 10, and 20 µM
IPTG and then assayed for β-galactosidase activity indicated on the x-axis. The
graph depicts the average of three independent measurements. β-galactosidase
activity is expressed in Miller units indicated on the y-axis. Error bars indicate
standard deviation.
ClpA Interaction with β-831-1059
α-ClpA + pAcI-β 831-1059 had a background value of 517 Miller units in the
absence of IPTG 579 Miller Units when induced with 2 μM IPTG, 970 Miller units when
induced with 10 μM IPTG, and 960 Miller Units when induced with 20 μM IPTG (Figure
15). Increasing amounts of IPTG should result in increased β-galactosidase production
from the lacZ test promoter. α-ClpA + pAcI-β 831-1059 increased to 970 Miller units at
10 μM IPTG and then decreased to 960 Miller units at 20 μM IPTG.
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The negative control pBRα-ClpA + pAcI had a background value of 132 Miller
units in the absence of IPTG, 200 Miller units when induced with 2 μM IPTG, 159 Miller
units when induced with 10 μM IPTG, and 130 Miller units when induced with 20 μM
IPTG. The negative control pBRα + pAcI-β 831-1059 had a background value of 204
Miller units in the absence of IPTG, 211 Miller units when induced with 2 μM IPTG, 212
Miller units when induced with 10 μM IPTG, and 181 Miller units when induced with 20
μM IPTG. The negative controls have low amounts β-galactosidase activity because only
one half of the interacting protein pairs are being expressed. In this situation in the
bacterial two-hybrid assay there is no protein-protein interaction happening so βgalactosidase activity is really low. α-ClpA + pAcI-β 831-1059 had ~3-fold increase in βgalactosidase activity at 10 μM and 20 μM IPTG compared to the negative controls
suggesting that we do, in fact, have an interaction.
pBRα-σ70 R4 + pAcI-βflap was used as a positive control and had a background
value of 546 Miller units in the absence of IPTG, 779 Miller units when induced with 2
μM IPTG, 1217 Miller units when induced with 10 μM IPTG, and 1350 Miller units
when induced with 20 μM IPTG. Increasing amounts of IPTG should result in increased
β-galactosidase production from the lacZ test promoter and the positive control
demonstrated that the assay was functioning correctly.
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Figure 15: Results of β-galactosidase assays performed with FW102 OL2-62 E.
coli reporter strain transformed with one plasmid that expresses an α-ClpA fusion
protein and with a second plasmid expressing pAcI-β 831-1059 cI-fusion of the E.
coli RNAP coreome. The positive control was the reporter strain transformed with
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain
transformed with one plasmid expressing the α-ClpA fusion protein and a second
plasmid expressing λcI. A second negative control was the reporter strain
transformed with one plasmid expressing just the α protein and a second plasmid
expressing the β 831-1059 cI-fusion. The plasmids directed the synthesis of
fusion proteins under the control of an IPTG-inducible promoters. Reporters
strains were grown in the absence or presence of 0, 2, 10 and 20 µM IPTG and
then assayed for β-galactosidase activity indicated on the x-axis. The graph
depicts the average of three independent measurements. β-galactosidase activity is
expressed in Miller units indicated on the y-axis. Error bars indicate standard
deviation.
DppF Interaction with β' 114-190
To study the strength of the interaction, α-DppF was tested against the previously
shown two interacting pieces of the RNAP coreome (β' 114-190 and β' 1137-1226) with
various concentrations of IPTG (Figure 16). α-DppF + pAcI-β' 114-190 had a
background value of 357 Miller units in the absence of IPTG, 843 Miller units when
induced with 2 μM IPTG, 1017 Miller units when induced with 10 μM IPTG, and 1564
Miller units when induced with 20 μM IPTG. Increasing amounts of IPTG should result
in increased β-galactosidase production from the lacZ test promoter.
65

The negative control pBRα-DppF + pAcI had a background value of 217 Miller
units in the absence of IPTG, 240 Miller units when induced with 2 μM IPTG, 394 Miller
units when induced with 10 μM IPTG, and 306 Miller units when induced with 20 μM
IPTG. The negative control pBRα + pAcI-β' 114-190 had a background value of 202
Miller units in the absence of IPTG, 189 Miller units when induced with 2 μM IPTG, 160
Miller units when induced with 10 μM IPTG, and 121 Miller units when induced with 20
μM IPTG. The negative controls have low amounts β-galactosidase activity because only
one half of the interacting protein pairs are being expressed. In this situation in the
bacterial two-hybrid assay there is no protein-protein interaction happening so βgalactosidase activity is really low. DppF + pAcI-β' 114-190 had ~3-fold increase in βgalactosidase activity at 10 μM IPTG and a ~5-fold increase in β-galactosidase activity at
20 μM IPTG compared to the negative controls suggesting that there is an interaction.
pBRα -σ70 R4 + pAcI-βflap was used as a positive control and had a background
value of 447 Miller units in the absence of IPTG, 799 Miller units when induced with 2
μM IPTG, 646 Miller units when induced with 10 μM IPTG, and 767 Miller units when
induced with 20 μM IPTG.
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Figure 16: Results of β-galactosidase assays performed with FW102 OL2-62 E.
coli reporter strain transformed with one plasmid that expresses an α- α-DppF
fusion protein and with a second plasmid expressing pAcI-β' 114-190 cI-fusion of
the E. coli RNAP coreome. The positive control was the reporter strain
transformed with plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was
the reporter strain transformed with one plasmid expressing the α-DppF fusion
protein and a second plasmid expressing λcI. A second negative control was the
reporter strain transformed with one plasmid expressing just the α protein and a
second plasmid expressing the β’ 114-190 cI-fusion. The plasmids directed the
synthesis of fusion proteins under the control of an IPTG-inducible promoters.
Reporters strains were grown in the absence or presence of 0, 2, 10 and 20 µM
IPTG and then assayed for β-galactosidase activity indicated on the x-axis. The
graph depicts the average of three independent measurements. β-galactosidase
activity is expressed in Miller units indicated on the y-axis. Error bars indicate
standard deviation.
DppF Interaction with β’ 1137-1226
α-DppF + pAcI-β' 1137-1226 had a background value of 368 Miller units in the
absence of IPTG, 1036 Miller units when induced with 2 μM IPTG, 1127 Miller units
when induced with 10 μM IPTG, and 1063 Miller units when induced with 20 μM IPTG
(Figure 17). Increasing amounts of IPTG should result in increased β-galactosidase
production from the lacZ test promoter.
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The negative control pBRα-DppF + pAcI had a background value of 124 Miller
units in the absence of IPTG, 128 Miller units when induced with 2 μM IPTG, 290 Miller
units when induced with 10 μM IPTG, and 256 Miller units when induced with 20 μM
IPTG. The negative control pBRα + β' 1137-1226 had a background value of 86 Miller
units in the absence of IPTG, 136 Miller units when induced with 2 μM IPTG, 124 Miller
units when induced with 10 μM IPTG, and 98 Miller units when induced with 20 μM
IPTG. The negative controls have low amounts β-galactosidase activity because only one
half of the interacting protein pairs are being expressed. In this situation in the bacterial
two-hybrid assay there is no protein-protein interaction happening so β-galactosidase
activity is really low. α-DppF + pAcI-β' 1137-1226 had ~4-fold increase in βgalactosidase activity at 10 μM and 20 μM IPTG compared to the negative controls
suggesting that there is an interaction.
pBRα -σ70 R4 + pAcI-βflap was used as a positive control and had a background
value of 819 Miller units in the absence of IPTG, 760 Miller units when induced with 2
μM IPTG, 798 Miller units when induced with 10 μM IPTG, and 1058 Miller units when
induced with 20 μM IPTG.
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Figure 17: Results of β-galactosidase assays performed with FW102 OL2-62 E.
coli reporter strain transformed with one plasmid that expresses an α-DppF fusion
protein and with a second plasmid expressing pAcI-β 1137-1226 cI-fusion of the
E. coli RNAP coreome. The positive control was the reporter strain transformed
with plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter
strain transformed with one plasmid expressing the α-DppF fusion protein and a
second plasmid expressing λcI. A second negative control was the reporter strain
transformed with one plasmid expressing just the α protein and a second plasmid
expressing the β 1137-1226 cI-fusion. The plasmids directed the synthesis of
fusion proteins under the control of an IPTG-inducible promoters. Reporters
strains were grown in the absence or presence of 0, 2, 10 and 20 µM IPTG and
then assayed for β-galactosidase activity indicated on the x-axis. The graph
depicts the average of three independent measurements. β-galactosidase activity is
expressed in Miller units indicated on the y-axis. Error bars indicate standard
deviation.
Tig Interaction with β' 735-790
α-Tig + pAcI -β' 735-790 had a background value of 619 Miller units in the
absence of IPTG, 1250 Miller units when induced with 2 μM IPTG, 400 Miller units
when induced with 10 μM IPTG, and 547 Miller units when induced with 20 μM IPTG
(Figure 18). Increasing amounts of IPTG should result in increased β-galactosidase
production from the lacZ test promoter.
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The negative control pBRα-Tig + pAcI had a background value of 57 Miller units
in the absence of IPTG, 177 Miller units when induced with 2 μM IPTG, 218 Miller units
when induced with 10 μM IPTG, and 211 Miller units when induced with 20 μM IPTG.
The negative control pBRα + β' 735-790 had a background value of 123 Miller units in
the absence of IPTG, 186 Miller units when induced with 2 μM IPTG, 169 Miller units
when induced with 10 μM IPTG, and 156 Miller units when induced with 20 μM IPTG.
The negative controls have low amounts β-galactosidase activity because only one half of
the interacting protein pairs are being expressed. In this situation in the bacterial twohybrid assay there is no protein-protein interaction happening so β-galactosidase activity
is really low. α-Tig + pAcI -β' 735-790 had ~5-fold increase in β-galactosidase activity at
2 μM IPTG compared to the negative controls suggesting that there is an interaction.
pBRα -σ70 R4 + pAcI-βflap was used as a positive control and had a background
value of 911 Miller units in the absence of IPTG, 1064 Miller units when induced with 2
μM IPTG, 901 Miller units when induced with 10 μM IPTG, and 933 Miller units when
induced with 20 μM IPTG. As depicted in Figure 18 there is a dramatic decrease in βgalactosidase activity in α-Tig + pAcI- β' 735-790. Overexpression of the fusion protein
could have toxic effects on the cell. The fusion protein could be interacting with other
proteins in the cell and disrupt normal protein-protein interactions. If the fusion protein is
interacting with RNAP, overexpression of the target protein could affect normal
transcription of other genes.
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Figure 18: Results of β-galactosidase assays performed with FW102 OL2-62 E.
coli reporter strain transformed with one plasmid that expresses an α-Tig fusion
protein and with a second plasmid expressing pAcI-β' 735-790 cI-fusion of the E.
coli RNAP coreome. The positive control was the reporter strain transformed with
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain
transformed with one plasmid expressing the α-Tig fusion protein and a second
plasmid expressing λcI. A second negative control was the reporter strain
transformed with one plasmid expressing just the α protein and a second plasmid
expressing the β' 735-790 cI-fusion. The plasmids directed the synthesis of fusion
proteins under the control of an IPTG-inducible promoters. Reporters strains were
grown in the absence or presence of 0, 2, 10 and 20 µM IPTG and then assayed
for β-galactosidase activity indicated on the x-axis. The graph depicts the average
of three independent measurements. β-galactosidase activity is expressed in Miller
units indicated on the y-axis. Error bars indicate standard deviation.
Tig Interaction with β 450-530
α-Tig + pAcI –β 450-530 had a background value of 360 Miller units in the
absence of IPTG, 901 Miller units when induced with 2 μM IPTG, 617 Miller units when
induced with 10 μM IPTG, and 1326 Miller units when induced with 20 μM IPTG
(Figure 19). Increasing amounts of IPTG should result in increased β-galactosidase
production from the lacZ test promoter.
The negative control pBRα-Tig + pAcI had a background value of 190 Miller
units in the absence of IPTG, 258 Miller units when induced with 2 μM IPTG, 334 Miller
units when induced with 10 μM IPTG, and 241 Miller units when induced with 20 μM
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IPTG. The negative control pBRα + pAcI –β 450-530 had a background value of 188
Miller in the absence of IPTG, 187 Miller units when induced with 2 μM IPTG, 185
Miller units when induced with 10 μM IPTG, and 171 Miller units when induced with 20
μM IPTG. The negative controls have low amounts β-galactosidase activity because only
one half of the interacting protein pairs are being expressed. In this situation in the
bacterial two-hybrid assay there is no protein-protein interaction happening so βgalactosidase activity is really low. α-Tig + pAcI –β 450-530 had ~3-fold increase in βgalactosidase activity at 2 μM IPTG and a ~5-fold increase in β-galactosidase activity
compared to the negative controls suggesting that there is an interaction.
pBRα -σ70 R4 + pAcI-βflap was used as a positive control and had a background
value of 627 Miller units in the absence of 0 μM IPTG, 1228 Miller units when induced
with 2 μM IPTG, 1096 Miller units when induced with 10μM IPTG, and 862 Miller units
when induced with 20 μM IPTG.
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Figure 19: Results of β-galactosidase assays performed with FW102 OL2-62 E.
coli reporter strain transformed with one plasmid that expresses an α-Tig fusion
protein and with a second plasmid expressing pAcI-β 450-530 cI-fusion of the E.
coli RNAP coreome. The positive control was the reporter strain transformed with
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain
transformed with one plasmid expressing the α-Tig fusion protein and a second
plasmid expressing λcI. A second negative control was the reporter strain
transformed with one plasmid expressing just the α protein and a second plasmid
expressing the β 450-530 cI-fusion. The plasmids directed the synthesis of fusion
proteins under the control of an IPTG-inducible promoters. Reporters strains were
grown in the absence or presence of 0, 2, 10 and 20 µM IPTG and then assayed
for β-galactosidase activity indicated on the x-axis. The graph depicts the average
of three independent measurements. β-galactosidase activity is expressed in Miller
units indicated on the y-axis. Error bars indicate standard deviation.

Validating Protein-Protein Interactions by Reversing the Order of the Fusion
Proteins Expressed by the Bait and Prey plasmids
If two proteins are really interacting in the bacterial two-hybrid assay, in principle
it should not matter which protein is fused to cI, and which protein is fused to the αsubunit of RNAP. Previously, RNAP interactions were shown with α-fusions of ClpA,
DppF, and Tig. Additional plasmid constructs were made that expressed cI-fusions of P.
aeruginosa ClpA, DppF, and Tig. These cI fusion proteins were then tested for
interactions with their appropriate targets on RNAP, this time fused to the α-subunit of
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RNAP. We predicted that the protein-protein interactions would remain the same
regardless of what the protein is fused too.
The assays were performed as before. The reporter strain was co-transformed with a
bait plasmid and a prey plasmid. The co-transformed reporter strain was then grown in
the presence of increasing amounts of IPTG (0, 10 and 20 µM). As the amount of IPTG
increases, this would lead to the increase in expression of the interacting target proteins
followed by a corresponding increase in β-galactosidase expression from the test
promoter.
ClpA Interactions with pBRα-β 829-930 and pBRα-β 831-1059
When the reporter strain was co-transformed with pAcI-ClpA + pBRα-β 829-930
or pAcI-ClpA + pBRα-β 831-1059, the β-galactosidase activity detected was similar to
the negative controls. pAcI-ClpA + pBRα-β 829-930 and had a background value of 152
Miller units in the absence of IPTG, 107 Miller units when induced with 10 μM IPTG,
and 102 Miller units when induced with 20 μM IPTG. pAcI-ClpA + pBRα-β 831-1059
had a background value of 267 Miller units in the absence of IPTG, 258 Miller units
when induced with 10μ M IPTG, and 307 Miller units when induced with 20 μM IPTG.
The negative control was the reporter strain co-transformed with pAcI-ClpA +
pBRα and it had a background value of 143 Miller units in the absence of IPTG, 59
Miller units when induced with 10 μM IPTG, and 72 Miller units when induced with 20
μM IPTG. pBRα-β 829-930 + pAcI had a background value of 219 Miller units in the
absence of IPTG, 290 Miller units when induced with 10 μM IPTG, and 109 Miller units
when induced with 20 μM IPTG. pBRα-β 831-1059 + pAcI had a background value of
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310 Miller units in the absence of IPTG, 387 Miller units when induced with 10 μM
IPTG, and 275 Miller units when induced with 20 μM IPTG.
From this data, it was interpreted that the cI-ClpA fusion protein had no
significant interaction with the α-β 829-930 or α-β 831-1059 fusion proteins. The assay
was clearly functioning because the positive control strain co-transformed with pBRα σ70 R4 + pAcI-βflap had a background value of 255 Miller units in the absence of IPTG,
1920 Miller units when induced with 10 μM IPTG, and 1043 Miller units when induced
with 20 μM IPTG (Figure 20). While it was surprising that there was no significant
interaction between ClpA and β 829-930 or ClpA and β 831-1059 when the fusion
protein order was in the reverse order, there is a potential explanation for this. ClpA is a
large protein comprised of 754 amino acids. A reasonable explanation is that ClpA fused
to the C-terminus of λcI results in steric hindrance, disrupting the dimerization of λcI that
is required for the N-terminus to bind to DNA (Kedzierska et al., 2007). Larger protein
fusions can be made to the α-subunit of RNAP because it contains a longer flexible
region that is less vulnerable to steric hindrance.
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Figure 20: Results of β-galactosidase assays performed with FW102 OL2-62 E.
coli reporter strain transformed with one plasmid that expresses an α-β 829-930
fusion protein with a second plasmid expressing pAcI-ClpA cI-fusion of the E.
coli RNAP coreome. Another plasmid expressed α- β 831-1059 fusion protein
with a second plasmid expressing pAcI-ClpA cI-fusion of the E. coli RNAP
coreome. The positive control was the reporter strain transformed with plasmid
pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain
transformed with one plasmid expressing the α-β 829-930 fusion protein and a
second plasmid expressing λcI. A second negative control was the reporter strain
transformed with one plasmid expressing α- β 831-1059 fusion protein and a
second plasmid expressing λcI. A third negative control was the reporter strain
transformed with one plasmid expressing just the α protein and a second plasmid
expressing the ClpA cI-fusion. The plasmids directed the synthesis of fusion
proteins under the control of an IPTG-inducible promoters. Reporters strains were
grown in the absence or presence of 0, 10 and 20 µM IPTG and then assayed for
β-galactosidase activity indicated on the x-axis. The graph depicts the average of
three independent measurements. β-galactosidase activity is expressed in Miller
units indicated on the y-axis. Error bars indicate standard deviation.
DppF Interactions with β' 114-190 and β 1137-1226
pAcI-DppF + pBRα-β' 114-190 had a background value of 769 Miller units in the
absence of IPTG, 1180 Miller units when induced with 10 μM IPTG, and 674 Miller
units when induced with 20 μM IPTG. pAcI-DppF + pBR α-β 1137-1226 had a
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background value of 175 Miller units in the absence of IPTG, 137 Miller units when
induced with 10 μM IPTG, and 128 Miller units when induced with 20 μM IPTG. The
negative control was the reporter strain co-transformed with pAcI-DppF + pBRα and had
a background value of 155 Miller units in the absence of IPTG, 121 Miller units when
induced with 10 μM IPTG, and 100 Miller units when induced with 20 μM IPTG. pBRαβ' 114-190 + pAcI had a background value of 313 Miller units in the absence of IPTG,
344 Miller units when induced with 10 μM IPTG, and 240 Miller units when induced
with 20 μM IPTG. pBRα-β 1137-1226 + pAcI had a background value of 131 Miller
units in the absence of IPTG, 207 Miller units when induced with 10 μM IPTG, and 165
Miller units when induced with 20 μM IPTG.
From this data, it was interpreted that the cI-DppF fusion protein had no
significant interaction with the α-β 1137-1226 fusion protein (Figure 21). This needs to
be further investigated. Further experiments in which α-DppF has been mutagenized
could be used to determine if the interaction with β 1137-1226 is real. DppF did have an
interaction with β' 114-190 and had a ~4-fold increase in β-galactosidase activity when
induced with 10 μM IPTG compared to the negative controls. This data suggests that
there is an interaction between DppF and β' 114-190 protein, but had no significant
interaction with β 1137-1226.
The assay was clearly functioning because the positive control strain cotransformed with pBRα -σ70 R4 + pAcI-βflap had a background value of 2255 Miller
units in the absence of IPTG, 3525 Miller units when induced with 10 μM IPTG, and
1001 Miller units when induced with 20 μM IPTG (Figure 21).
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Figure 21: Results of β-galactosidase assays performed with FW102 OL2-62 E.
coli reporter strain transformed with one plasmid that expresses an α-β’ 114-190
fusion protein with a second plasmid expressing pAcI-DppF cI-fusion of the E.
coli RNAP coreome. Another plasmid expressed α- β’ 1137-1226 fusion protein
with a second plasmid expressing pAcI-DppF cI-fusion of the E. coli RNAP
coreome. The positive control was the reporter strain transformed with plasmid
pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain
transformed with one plasmid expressing the α-β’ 114-190 fusion protein and a
second plasmid expressing λcI. A second negative control was the reporter strain
transformed with one plasmid expressing α- β’ 1137-1226 fusion protein and a
second plasmid expressing λcI. A third negative control was the reporter strain
transformed with one plasmid expressing just the α protein and a second plasmid
expressing the DppF cI-fusion. The plasmids directed the synthesis of fusion
proteins under the control of an IPTG-inducible promoters. Reporters strains were
grown in the absence or presence of 0, 10 and 20 µM IPTG and then assayed for
β-galactosidase activity indicated on the x-axis. The graph depicts the average of
three independent measurements. β-galactosidase activity is expressed in Miller
units indicated on the y-axis. Error bars indicate standard deviation.
Tig Interactions with β’ 735-790 and β 450-530
cI-Tig + α-β' 735-790 had a background value of 304 Miller units in the absence
of IPTG, 698 Miller units when induced with 10 μM IPTG, and 542 Miller units when
induced with 20 μM IPTG. pAcI-Tig + pBR α-β 450-530 had a background value of 174
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Miller units in the absence of IPTG, 593 Miller units when induced with 10 μM IPTG,
and 574 Miller units when induced with 20 μM IPTG.
The negative control was the reporter strain co-transformed with pAcI-Tig +
pBRα and it had a background value of 42 Miller units in the absence of IPTG, 71 Miller
units when induced with 10 μM IPTG, and 51 Miller units when induced with 20 μM
IPTG. pBRα-β' 735-790 + pAcI had a background value of 291 Miller units in the
absence of IPTG, 291 Miller units when induced with 10 μM IPTG, and 148 Miller units
when induced with 20 μM IPTG. pBRα-β 450-530 + pAcI had a background value of 141
Miller units in the absence of IPTG, 141 Miller units when induced with 10 μM IPTG,
and 190 Miller units when induced with 20 μM IPTG.
cI-Tig + α-β' 735-790 and cI-Tig + α-β 450-530 had ~2-fold increase in βgalactosidase activity at 10 and 2 μM IPTG compared to the negative controls. From this
data, it was interpreted that the cI-Tig fusion protein had a significant interaction with the
α- β' 735-790 and α-β 450-530 fusion proteins at 10 and 20 μM IPTG. Although only a 2fold increase in β-galactosidase activity was detected, this does indicate the interaction is
real. The assay was clearly functioning because the positive control strain co-transformed
with pBRα -σ70 R4 + pAcI-βflap had a background value of 1548 Miller units in the
absence of IPTG, 1661 Miller units when induced with 10 μM IPTG, and 969 Miller
units when induced with 20 μM IPTG. The decrease in Miller units is likely due to the
overexpression of these proteins in the cell that consume cellular resources that might be
needed for normal transcription/translation. Also, overexpressing proteins that are
interacting with RNAP could disrupt the normal function of RNAP in the cell and disrupt
normal transcription (Figure 22).
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Figure 22: Results of β-galactosidase assays performed with FW102 OL2-62 E.
coli reporter strain transformed with one plasmid that expresses an α-β’ 735-790
fusion protein with a second plasmid expressing pAcI-Tig cI-fusion of the E. coli
RNAP coreome. Another plasmid expressed α- β 450-530 fusion protein with a
second plasmid expressing pAcI-Tig cI-fusion of the E. coli RNAP coreome. The
positive control was the reporter strain transformed with plasmid pBRα -σ70 R4 +
pAcI-βflap. One negative control was the reporter strain transformed with one
plasmid expressing the α-β’ 735-790 fusion protein and a second plasmid
expressing λcI. A second negative control was the reporter strain transformed
with one plasmid expressing α- β 450-530 fusion protein and a second plasmid
expressing λcI. A third negative control was the reporter strain transformed with
one plasmid expressing just the α protein and a second plasmid expressing the Tig
cI-fusion. The plasmids directed the synthesis of fusion proteins under the control
of an IPTG-inducible promoters. Reporters strains were grown in the absence of
presence of 0, 10 and 20 µM IPTG and then assayed for β-galactosidase activity
indicated on the x-axis. The graph depicts the average of three independent
measurements. β-galactosidase activity is expressed in Miller units indicated on
the y-axis. Error bars indicate standard deviation.
Defining Tig interaction sites with RNAP.
Domains of α-Tig (1-3)
Tig was chosen for further investigation because it had the highest interaction out
of the 3 P. aeruginosa target proteins tested. E. coli Tig also had one of the strongest
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interactions with RNAP (P. Deighan, Personal Communication and Figure 13). Tig
interaction with β' 735-790 had an ~8-fold increase in β-galactosidase activity compared
to the negative controls (Figure 12). Tig interaction with β 450-530 had a ~12-fold
increase in β-galactosidase activity compared to the negative control (Figure 12). Tig has
3 structural domains. To individually test each domain, the domains were broken up
based on the amino acid sequences 1-149 for α-Tig Domain 1, 149-245 for α-Tig Domain
2, 245-532 for α-Tig Domain 3, 1 – 245 for α-Tig Domain 1+ 2, and 149-432 for α-Tig
Domain 2+3 (Figure 11). These experiments were performed to further define the site of
interaction between Tig and RNAP.
Tig Domain 1 Interactions with β' 735-790 and β 450-530
When the reporter strain was co-transformed with pBRα-Tig Domain 1+ pAcI-β'
735-790 or pBRα-Tig Domain 1 + pAcI-β 450-530 the β-galactosidase activity generated
from the test promoter was comparable to the negative control under all IPTG conditions
(Figure 24). pBRα-Tig Domain 1+ pAcI-β' 735-790 had a background value of 252
Miller units in the absence of IPTG, 409 Miller units when induced with 10 μM IPTG,
and 295 Miller units when induced with 20 μM IPTG. pBRα-Tig Domain 1 + pAcI-β
450-530 had a background value of 324 Miller units in the absence of IPTG, 273 Miller
units when induced with 10 μM IPTG, and 161 Miller units when induced with 20 μM
IPTG. The negative control tested the interaction between Tig Domain 1 and λcI and had
a background value of 206 Miller units in the absence of IPTG, 315 Miller units when
induced with 10 μM IPTG, and 187 Miller units when induced with 20 μM IPTG.
These results suggest that Tig Domain 1 had no significant interaction with RNAP
β' 735-790 or β 450-530. The assay was functioning because the positive control pBRα-
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σ70 R4 + pAcI-βflap had a background value of 510 Miller units in the absence of IPTG,
3188 Miller units when induced with 10 μM IPTG, and 1173 Miller units when induced
with 20 μM IPTG. There is a dramatic decrease in β-galactosidase activity in α-σ70 R4 +
pAcI-βflap at 20 μM IPTG. Overexpression of the fusion protein could have toxic effects
on the cell for the previously mentioned reasons.

Figure 23: Results of bacterial two-hybrid assays performed with the FW102 OL262 E. coli reporter strain transformed with one plasmid that expresses an α-Tig
Domain 1 fusion protein and with a second plasmid expressing β' 735-790 or β
450-530 fused to cI. The positive control was the reporter strain transformed with
plasmid pBRα -σ 70 R4 + pAcI-βflap. One negative control was the reporter
strain transformed with one plasmid expressing the α-Tig Domain 1 fusion protein
and a second plasmid expressing λcI. The plasmids directed the synthesis of
fusion proteins under the control of an IPTG-inducible promoters. Reporters
strains were grown in the absence or presence of 0, 10 and 20 µM IPTG and then
assayed for β-galactosidase activity indicated on the x-axis. The graph depicts the
average of three independent measurements. β-galactosidase activity is expressed
in Miller units indicated on the y-axis. Error bars indicate standard deviation.
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Tig Domain 2 Interactions with β' 735-790 and β 450-530
When the reporter strain was co-transformed with pBRα-Tig Domain 2 + pAcI-β'
735-790 or pBRα-Tig Domain 2 + pAcI-β 450-530 the β-galactosidase activity generated
from the test promoter was comparable to the negative control under all IPTG conditions
(Figure 24). pBRα-Tig Domain 2 + pAcI-β' 735-790 had a background value of 282
Miller units in the absence of IPTG, 451 Miller units when induced with 10 μM IPTG,
and 458 Miller units when induced with 20 μM IPTG. pBRα-Tig Domain 2 + pAcI-β
450-530 had a background value of 267 Miller units in the absence of IPTG, 355 Miller
units when induced with 10 μM IPTG, and 294 Miller units when induced with 20 μM
IPTG.
The negative control tested the interaction between Tig Domain 2 and λcI and had
a background value of 276 Miller units in the absence of IPTG, 399 Miller units when
induced with 10 μM IPTG, and 271 Miller units when induced with 20 μM IPTG. These
results suggest that Tig Domain 2 had no significant interaction with RNAP β' 735-790 or
β 450-530. The assay was functioning because the positive control pBRα-σ70 R4 + pAcIβflap had a background value of 536 Miller units in the absence of IPTG, 1370 Miller
units when induced with 10 μM IPTG, and 1764 Miller units when induced with 20 μM
IPTG (Figure 24).
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Figure 24: Results of bacterial two-hybrid assays performed with the FW102 OL262 E. coli reporter strain transformed with one plasmid that expresses an α-Tig
Domain 2 fusion protein and with a second plasmid expressing β' 735-790 or β
450-530 fused to cI. The positive control was the reporter strain transformed with
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain
transformed with one plasmid expressing the α-Tig Domain 2 fusion protein and a
second plasmid expressing λcI. The plasmids directed the synthesis of fusion
proteins under the control of an IPTG-inducible promoters. Reporters strains were
grown in the absence or presence of 0, 10 and 20 µM IPTG and then assayed for
β-galactosidase activity indicated on the x-axis. The graph depicts the average of
three independent measurements. β-galactosidase activity is expressed in Miller
units indicated on the y-axis. Error bars indicate standard deviation.
Tig Domain 3 Interactions with β' 735-790 and β 450-530
When the reporter strain was co-transformed with pBRα-Tig Domain 3+ pAcI-β'
735-790 or pBRα-Tig Domain 3 + pAcI-β 450-530 the β-galactosidase activity generated
from the test promoter was comparable to the negative control under all IPTG conditions
(Figure 25). pBRα-Tig Domain 3+ pAcI-β' 735-790 had a background value of 175
Miller units in the absence of IPTG, 190 Miller units when induced with 10 μM IPTG,
and 226 Miller units when induced with 20 μM IPTG. pBRα-Tig Domain 3 + pAcI-β
450-530 had a background value of 149 Miller units in the absence of IPTG, 130 Miller
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units when induced with 10 μM IPTG, and 166 Miller units when induced with 20 μM
IPTG.
The negative control tested the interaction between Tig Domain 3 and λcI and had
a background value of 167 Miller units in the absence of IPTG, 205 Miller units when
induced with 10 μM IPTG, and 159 Miller units when induced with 20 μM IPTG. These
results suggest that Tig Domain 3 had no significant interaction with RNAP β' 735-790 or
β 450-530. The assay was functioning because the positive control pBRα-σ70 R4 + pAcIβflap had a background value of 1266 Miller units in the absence of IPTG, 3876 Miller
units when induced with 10 μM IPTG, and 1313 Miller units when induced with 20 μM
IPTG. There is a dramatic decrease in β-galactosidase activity in α-σ70 R4 + pAcI-βflap at
20 μM IPTG. Over expression of the fusion protein could have toxic effects on the cell
for the previously mentioned reasons. Together these results suggest that the Tig
interaction site with RNAP is not localized to a single Tig domain.
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Figure 25: Results of bacterial two-hybrid assays performed with the FW102 OL262 E. coli reporter strain transformed with one plasmid that expresses an α-Tig
Domain 3 fusion protein and with a second plasmid expressing β' 735-790 or β
450-530 fused to cI. The positive control was the reporter strain transformed with
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain
transformed with one plasmid expressing the α-Tig Domain 3 fusion protein and a
second plasmid expressing λcI. The plasmids directed the synthesis of fusion
proteins under the control of an IPTG-inducible promoters. Reporters strains were
grown in the absence or presence of 0, 10 and 20 µM IPTG and then assayed for
β-galactosidase activity indicated on the x-axis. The graph depicts the average of
three independent measurements. β-galactosidase activity is expressed in Miller
units indicated on the y-axis. Error bars indicate standard deviation.
Tig Domains 1+2 interactions with RNAP β' 735-790 and β 450-530
Since there was no interaction detected between the individual Tig domains and
RNAP, it could be possible that the Tig interaction site with RNAP spans multiple
domains. In the following set of experiments Tig domains 1+2 and 2+3 were cloned into
the pBRα expression vector. Bacterial two-hybrid experiments were then performed with
Tig domains 1+2 and Tig domains 2+3. When the reporter strain was co-transformed
with pBRα-Tig Domain 1+2 + pAcI-β' 735-790 or pBRα-Tig Domain 1+2 + pAcI-β 450530 the β-galactosidase activity generated from the test promoter was comparable to the
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negative control under all IPTG conditions (Figure 26). pBRα-Tig Domain 1+2 + pAcI-β'
735-790 had a background value of 322 Miller units in the absence of IPTG, 468 Miller
units when induced with 10 μM IPTG, and 333 Miller units when induced with 20 μM
IPTG. pBRα-Tig Domain 1+2 + pAcI-β 450-530 had a background value of 329 Miller
units when in the absence of IPTG, 395 Miller units when induced with 10 μM IPTG, and
257 Miller units when induced with 20 μM IPTG.
The negative control tested the interaction between Tig Domain 1+2 and λcI and
had a background value of 298 Miller units in the absence of IPTG, 389 Miller units
when induced with 10 μM IPTG, and 285 Miller units when induced with 20 μM IPTG.
These results suggest that Tig Domain 1+2 had no significant interaction with RNAP β'
735-790 or β 450-530. The assay was functioning because the positive control pBRα-σ70
R4 + pAcI-βflap had a background value of 437 Miller units in the absence of IPTG, 862
Miller units when induced with 10 μM IPTG, and 1869 Miller units when induced with
20 μM IPTG (Figure 26).
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Figure 26: Results of bacterial two-hybrid assays performed with the FW102 OL262 E. coli reporter strain transformed with one plasmid that expresses an α-Tig
Domain 1+2 fusion protein and with a second plasmid expressing β' 735-790 or β
450-530 fused to cI. The positive control was the reporter strain transformed with
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain
transformed with one plasmid expressing the α-Tig Domain 1+2 fusion protein
and a second plasmid expressing λcI. The plasmids directed the synthesis of
fusion proteins under the control of an IPTG-inducible promoters. Reporters
strains were grown in the absence or presence of 0, 10 and 20 µM IPTG and then
assayed for β-galactosidase activity indicated on the x-axis. The graph depicts the
average of three independent measurements. β-galactosidase activity is expressed
in Miller units indicated on the y-axis. Error bars indicate standard deviation.
Tig Domains 2+3 interactions with RNAP β' 735-790 and β 450-530
When the reporter strain was co-transformed with pBRα-Tig Domain 2+3 +
pAcI-β' 735-790 or pBRα-Tig Domain 2+3 + pAcI-β 450-530 the β-galactosidase activity
generated from the test promoter was comparable to the negative control under all IPTG
conditions (Figure 27). pBRα-Tig Domain 2+3 + pAcI-β' 735-790 had a background
value of 232 Miller units in the absence of IPTG, 333 Miller units when induced with 10
μM IPTG, and 313 Miller units when induced with 2 μM IPTG. pBRα-Tig Domain 2+3 +
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pAcI-β 450-530 had a background value of 235 Miller units in the absence of IPTG, 226
Miller units when induced with 10 μM IPTG, and 289 Miller units when induced with 20
μM IPTG.
The negative control tested the interaction between Tig Domain 2+3 and λcI and
had a background value of 431 Miller units in the absence of IPTG, 373 Miller units
when induced with 10 μM IPTG, and 350 Miller units when induced with 20 μM IPTG.
These results suggest that Tig Domain 2+3 had no significant interaction with RNAP β'
735-790 or β 450-530. The assay was functioning because the positive control pBRα-σ70
R4 + pAcI-βflap had a background value of 832 Miller units in the absence of IPTG, 797
Miller units when induced with 10 μM IPTG, and 677 Miller units when induced with 20
μM IPTG (Figure 27).
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Figure 27: Results of bacterial two-hybrid assay performed with the FW102 OL262 E. coli reporter strain transformed with one plasmid that expresses an α-Tig
Domain 2+3 fusion protein and with a second plasmid expressing β' 735-790 or β
450-530 fused to cI. The positive control was the reporter strain transformed with
plasmid pBRα -σ70 R4 + pAcI-βflap. One negative control was the reporter strain
transformed with one plasmid expressing the α-Tig Domain 2+3 fusion protein
and a second plasmid expressing λcI. The plasmids directed the synthesis of
fusion proteins under the control of an IPTG-inducible promoters. Reporters
strains were grown in the presence of 0,10 and 20 µM IPTG and then assayed for
β-galactosidase activity indicated on the x-axis. The graph depicts the average of
three independent measurements. β-galactosidase activity is expressed in Miller
units indicated on the y-axis. Error bars indicate standard deviation.
In summary, no single Tig domain was found to interact with β’ 735-790 or β
450-530 of RNAP. One explanation could be that multiple Tig domains are required for
the interaction with RNAP. However, in this assay the combinations of Tig domains 1+2
and 2+3 also did not show interaction with RNAP. The crystal structure of Tig indicates
it is a highly structured protein (Hoffmann et al., 2010). Without all three domains
present the protein may not fold into the correct 3-dimensional configuration to interact
with RNAP.
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CONCLUSION

The purpose of this study was to determine if using an E. coli RNAP coreome
could be used to detect RNAP-interacting proteins in P. aeruginosa. A bacterial twohybrid assay was used as a tool to study protein-protein interactions. In summary, we
found that out of the 16 proteins initially screened, α-ClpA, α-DppF, and α-Tig interacted
with the E. coli RNAP coreome. α-ClpA interacted with β 829-930 and β 831-1059. αDppF interacted with β' 114-190 and β 1137-1226. α-Tig interacted with β' 735-790 and β
450-530 of the RNAP coreome. These proteins were further investigated to test the
strength of each interacting protein with various amounts of IPTG.
Reversing the orientation of the fusion proteins expressed by the bait and prey
plasmids were also conducted and β-galactosidase assays were performed. We found that
when the reporter strain was co-transformed with pAcI-ClpA + pBRα-β 829-930 or pAcIClpA + pBRα-β 831-1059, the β-galactosidase activity detected was similar to the
negative controls. Because ClpA is a large protein we think that ClpA fused to the C
terminus of λcI results in steric hindrance, disrupting the dimerization of λcI that is
required for the N terminus to bind to DNA.
DppF fusion protein had no significant interaction with the α-β 1137-1226 fusion
protein. cI-DppF did however have an interaction with α-β' 114-190 and had a ~4-fold
increase in β-galactosidase activity when induced with 10μM IPTG compared to the
negative controls. This data suggests that there is an interaction between cI-DppF fusion
protein α-β' 114-190. α-β 1137-1226 fusion protein did not have an interaction and
should be further investigated to determine if the interaction is real.
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pAcI-Tig + pBRα-β' 735-790 and pAcI-Tig + pBR α-β 450-530 had ~2-fold
increase in β-galactosidase activity at 10 and 20μM IPTG compared to the negative
controls. From this data, it was interpreted that the cI-Tig fusion protein had a significant
interaction with the α- β' 735-790 and α-β 450-530 fusion protein at 10 and 20μM IPTG.
Although not a huge interaction, this does indicate the interaction is real. Figure 28
depicts mapping of the interactions with each target protein and pieces of the E. coli
RNAP coreome. The center indicates the RNAP holoenzyme and each piece of RNAP.

Figure 28: Crystal structure of the E. coli RNAP fragments that interacted with P.
aeruginosa RNAP-interacting proteins. Image created with PyMol and Protein
Data Bank structure 4MEY. Degen et al., Elife, 2014.
α-Tig was chosen for further investigation. It was found to interact with β 450530. This was similar to what was found with E. coli Tig (performed by Padraig
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Deighan). To further define which region of Tig interacted with RNAP, we studied how
the individual domains interacted with RNAP β' 735-790 and β 450-530. This was
performed to localize where RNAP interacts on Tig. No single Tig domain was found to
interact with β’ 735-790 or β 450-530 of RNAP. One explanation could be that multiple
Tig domains are required for the interaction with RNAP. Without all three domains
present the protein may not fold in the correct 3-dimensional configuration to interact
with RNAP.
One strategy that could be used to define the region of Tig interaction with RNAP
would be to make N-terminal or C-terminal deletion mutants. Progressively shorter Tig
mutants could be made and tested to see when they fail to interact with RNAP β' 735-790
and β 450-530. While ClpA, DppF, and Tig have not been specifically involved in
virulence, this study is proof of concept that utilizing an E. coli RNAP coreome is
possible to study P. aeruginosa RNAP-interacting proteins. The E. coli RNAP is an
effective platform to study RNAP-interacting proteins in P. aeruginosa.
As multidrug resistance P. aeruginosa becomes more prevalent, novel treatments
are necessary to combat these infections. Currently, antibiotics target a small number of
essential gene functions such as inhibition of cell wall synthesis, DNA replication, RNA
transcription and protein synthesis. Virulence gene expression in vivo represents a
potential target for antibiotic discovery. Utilizing a RNAP coreome to identify potential
TFs in P. aeruginosa could result in the development of new antimicrobials that block
virulence factors. Blocking the function of virulence factors (or their expression) could
limit pathogen colonization, damage to host cells, and aid the host immune system in
successful elimination of the pathogen. Furthermore, a RNAP coreome could be used to
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discover essential RNAP interacting proteins. Essential RNAP interacting proteins could
also be targets for novel antimicrobials. Disrupting the function of such essential proteins
could lead to the death of the pathogen.
There is data supporting the concept that the E. coli RNAP coreome can be used
to identify proteins associated with virulence that interact with RNAP. In Hung et al.,
2005 a high-throughput, phenotypic screen was used to identify a small molecule
virstatin, that inhibits virulence regulation in Vibrio cholerae. By inhibiting the
transcriptional regulator ToxT interaction with RNAP, virstatin prevents expression of
two crucial virulence factors, cholera toxin and the toxin coregulated pilus. The bacterial
two-hybrid assay was used to understand how virstatin worked. The experiments with
virstatin demonstrate that, in principle, it might be possible to design drugs that disrupt
interaction or function of this protein with RNAP.
There are some limitations to utilizing a bacterial two-hybrid assay to study
RNAP-interacting proteins with the E. coli RNAP coreome. pAcI-α 2-235 R45A of the
coreome appears to be a sticky protein fragment. In over 60 target proteins tested with the
coreome assay, α 2-235 R45A has been implicated in many non-specific interactions. In
this study, out of the 16 proteins, 5 screened proteins had an interaction with this piece of
the RNAP coreome. These interactions were not investigated further because of the risk
of exploring non-specific interactions.
Other limitations of this system are that the fusion proteins are being induced with
at most 20 μM of IPTG and therefore are not being overly expressed in most cases. The
bacterial two-hybrid assay will not detect all TF-RNAP interactions. For example, weak
interactions, DNA-dependent interactions, bridged interactions, or poorly expressed α
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fusions may lead to a false negative outcome. Further research should be conducted on
mutagenesis of the α-fusion proteins due to the possibility of bridged interactions. Also
cloning the corresponding E. coli RNAP coreome pieces from P. aeruginosa and cloning
it to the λcI protein would be another way to verify that the interaction is taking place in
P. aeruginosa.
While this work was able to demonstrate that an E. coli RNAP coreome could be
utilized to study P. aeruginosa RNAP-interacting proteins, it is possible to optimize this
system. To optimally study RNAP interacting proteins in P. aeruginosa, a P. aeruginosa
coreome library could be constructed. The slight differences between P. aeruginosa and
E. coli RNAP might result in some P. aeruginosa RNAP-protein interactions to be
missed. Screening P. aeruginosa proteins against a P. aeruginosa RNAP coreome would
decrease the likelihood of missing real interactions.
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APPENDIX A

ALIGNMENTS OF THE E. COLI RNAP COREOME TO THE CORESPONDING
PIECES IN P. AERUGINOSA

Figure 35A: pBLAST Alignment of Pseudomonas aeruginosa RNAP α 2-235 (top) to
Escherichia coli RNAP α 2-235 (bottom).

Figure 35B: pBLAST Alignment of Pseudomonas aeruginosa RNAP α 249-329 (top) to
Escherichia coli RNAP α 249-329 (bottom).
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Figure 35C: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 1-151 (top) to
Escherichia coli RNAP β 1-151 (bottom).

Figure 35D: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 1-235 (top) to
Escherichia coli RNAP β 1-235 (bottom).

Figure 35E: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 25-104 (top) to
Escherichia coli RNAP β’ 25-104 (bottom).
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Figure 35F: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 114-190 (top) to
Escherichia coli RNAP β’ 114-190 (bottom).

Figure 35G: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 140-235 (top) to
Escherichia coli RNAP β’ 140-235 (bottom).
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Figure 35H: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 151-451 (top) to
Escherichia coli RNAP β 151-451 (bottom).

Figure 35I: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 193-230 (top) to
Escherichia coli RNAP β’ 193-230 (bottom).
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Figure 35J: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 235-650 (top) to
Escherichia coli RNAP β 235-650 (bottom).

Figure 35K: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 249-328 (top) to
Escherichia coli RNAP β’ 249-328 (bottom).

Figure 35L: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 264-308 (top) to
Escherichia coli RNAP β’ 264-308 (bottom).
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Figure 35M: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 370-416 (top) to
Escherichia coli RNAP β’ 370-416 (bottom).

Figure 35N: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 450-530 (top) to
Escherichia coli RNAP β 450-530 (bottom).

Figure 35O: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 516-573 (top) to
Escherichia coli RNAP β’ 516-573 (bottom).

Figure 35P: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 528-589 (top) to
Escherichia coli RNAP β 528-589 (bottom).
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Figure 35Q: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 528-656 (top) to
Escherichia coli RNAP β 528-656 (bottom).

Figure 35R: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 576-634 (top) to
Escherichia coli RNAP β’ 576-634 (bottom).

Figure 35S: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 587-656 (top) to
Escherichia coli RNAP β 587-656 (bottom).
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Figure 35T: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 648-701 (top) to
Escherichia coli RNAP β’ 648-701 (bottom).

Figure 35U: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 650-950 (top) to
Escherichia coli RNAP β 650-950 (bottom).

Figure 35V: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 665-798 (top) to
Escherichia coli RNAP β 665-798 (bottom).
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Figure 35W: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 703-795 (top) to
Escherichia coli RNAP β 703-795 (bottom).

Figure 35X: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 735-790 (top) to
Escherichia coli RNAP β’ 735-790 (bottom).

Figure 35Y: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 820-882 (top) to
Escherichia coli RNAP β’ 820-882 (bottom).
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Figure 35Z: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 829-930 (top) to
Escherichia coli RNAP β 829-930 (bottom).

Figure 35AA: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 831-1059 (top)
to Escherichia coli RNAP β 831-1059 (bottom).

Figure 35BB: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 930-1059 (top)
to Escherichia coli RNAP β 930-1059 (bottom).
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Figure 35CC: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 944-1021 (top)
to Escherichia coli RNAP β’ 944-1021 (bottom).

Figure 35DD: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 944-1133 (top)
to Escherichia coli RNAP β’ 944-1133 (bottom).
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Figure 35EE: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 950-1342 (top)
to Escherichia coli RNAP β 950-1342 (bottom).

Figure 35FF: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 1023-1128
(top) to Escherichia coli RNAP β’ 1023-1128 (bottom).

Figure 35GG: pBLAST Alignment of Pseudomonas aeruginosa RNAP β 1137-1226
(top) to Escherichia coli RNAP β 1137-1226 (bottom).
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Figure 35HH: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 1137-1243
(top) to Escherichia coli RNAP β’ 1137-1243 (bottom).

Figure 35II: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 1154-1212 (top)
to Escherichia coli RNAP β’ 1154-1212 (bottom).

Figure 35JJ: pBLAST Alignment of Pseudomonas aeruginosa RNAP β’ 1261-1307 (top)
to Escherichia coli RNAP β’ 1261-1307 (bottom).
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Figure 35KK: pBLAST Alignment of Pseudomonas aeruginosa RNAP σ 94-448 (top) to
Escherichia coli RNAP σ 94-448 (bottom).

Figure 35LL: pBLAST Alignment of Pseudomonas aeruginosa RNAP σ 528-613 (top) to
Escherichia coli RNAP σ 528-613 (bottom).
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APPENDIX B

RNAP COREOME SCREENING OF PROTEINS WITH NO SIGNIFICANT
INTERACTION

Figure 29: RNAP coreome screen displaying AtpD interactions with RNAP-α 2235 R45A. Diagram shows β-galactosidase transcription activation of a bacterial
two-hybrid assay. This assay depicts interaction of an α-fusion of AtpD with cIfusion of the RNAP coreome. The dashed line indicates the average background
level of β-galactosidase activity. pBRα and pACλcI plasmids directed the
synthesis of fusion proteins under the control of IPTG-inducible promoters. The
co-transformed FW102 OL2-62 reporter strain was grown in the presence of 20
µM IPTG and then assayed for β-galactosidase activity. β-galactosidase activity is
expressed in Miller units indicated on the y-axis. The x-axis indicates the
individual E. coli RNAP coreome fragments being expressed in the reporter
strain.
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Figure 30: RNAP coreome screen displaying no interaction of ClpB. Diagram
shows β-galactosidase transcription activation of a bacterial two-hybrid assay.
This assay depicts no interaction of an α-fusion of ClpB with cI-fusion of the
RNAP coreome. The dashed line indicates the average background level of βgalactosidase activity. pBRα and pACλcI plasmids directed the synthesis of
fusion proteins under the control of IPTG-inducible promoters. The cotransformed FW102 OL2-62 reporter strain was grown in the presence of 20 µM
IPTG and then assayed for β-galactosidase activity. β-galactosidase activity is
expressed in Miller units indicated on the y-axis. The x-axis indicates the
individual E. coli RNAP coreome fragments being expressed in the reporter
strain.
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Figure 31: RNAP coreome screen displaying GcvP interaction with RNAP-α 2235 R45A. Diagram shows β-galactosidase transcription activation of a bacterial
two-hybrid assay. This assay depicts interaction of an α-fusion of GcvP with cIfusion of the RNAP coreome. The dashed line indicates the average background
level of β-galactosidase activity. pBRα and pACλcI plasmids directed the
synthesis of fusion proteins under the control of IPTG-inducible promoters. The
co-transformed FW102 OL2-62 reporter strain was grown in the presence of 20
µM IPTG and then assayed for β-galactosidase activity. β-galactosidase activity is
expressed in Miller units indicated on the y-axis. The x-axis indicates the
individual E. coli RNAP coreome fragments being expressed in the reporter
strain.

121

Figure 32: RNAP coreome screen displaying no interaction with Lon. Diagram
shows β-galactosidase transcription activation of a bacterial two-hybrid assay.
This assay depicts no interaction of an α-fusion of Lon with cI-fusion of the
RNAP coreome. The dashed line indicates the average background level of βgalactosidase activity. pBRα and pACλcI plasmids directed the synthesis of
fusion proteins under the control of IPTG-inducible promoters. The cotransformed FW102 OL2-62 reporter strain was grown in the presence of 20 µM
IPTG and then assayed for β-galactosidase activity. β-galactosidase activity is
expressed in Miller units indicated on the y-axis. The x-axis indicates the
individual E. coli RNAP coreome fragments being expressed in the reporter
strain.
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Figure 33: RNAP coreome screen displaying no interaction with PstB. Diagram
shows β-galactosidase transcription activation of a bacterial two-hybrid assay.
This assay depicts no interaction of an α-fusion of PstB with cI-fusion of the
RNAP coreome. The dashed line indicates the average background level of βgalactosidase activity. pBRα and pACλcI plasmids directed the synthesis of
fusion proteins under the control of IPTG-inducible promoters. The cotransformed FW102 OL2-62 reporter strain was grown in the presence of 20 µM
IPTG and then assayed for β-galactosidase activity. β-galactosidase activity is
expressed in Miller units indicated on the y-axis. The x-axis indicates the
individual E. coli RNAP coreome fragments being expressed in the reporter
strain.
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Figure 34: RNAP coreome screen displaying no interaction with PyrG. Diagram
shows β-galactosidase transcription activation of a bacterial two-hybrid assay.
This assay depicts no interaction of an α-fusion of PyrG with cI-fusion of the
RNAP coreome. The dashed line indicates the average background level of βgalactosidase activity. pBRα and pACλcI plasmids directed the synthesis of
fusion proteins under the control of IPTG-inducible promoters. The cotransformed FW102 OL2-62 reporter strain was grown in the presence of 20 µM
IPTG and then assayed for β-galactosidase activity. β-galactosidase activity is
expressed in Miller units indicated on the y-axis. The x-axis indicates the
individual E. coli RNAP coreome fragments being expressed in the reporter
strain.
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